Ehlers-danlos Syndrome
Ehlers-Danlos syndrome is a group of inherited connective tissue disorders caused by defects in collagen synthesis or structure, characterized by joint hypermobility, skin hyperextensibility, and tissue fragility.
Ehlers-Danlos Syndrome (EDS)
Ehlers-Danlos syndrome (EDS) is a clinically and genetically heterogeneous group of heritable connective tissue disorders characterised by abnormalities in the structure, production, or processing of collagen or proteins that interact with collagen. The name itself doesn't encode the pathology (it is eponymous, named after Edvard Ehlers, a Danish dermatologist, and Henri-Alexandre Danlos, a French physician, who independently described the condition in the early 1900s), but the hallmark clinical triad is:
- Joint hypermobility (excessive range of motion beyond normal limits)
- Skin hyperextensibility (skin stretches far beyond normal and recoils)
- Tissue fragility (easy bruising, poor wound healing, vascular/organ rupture in severe types)
The fundamental concept: collagen is the most abundant structural protein in the human body — it is the "scaffolding" of connective tissue. When collagen is defective in quantity, quality, or cross-linking, every tissue that depends on it (skin, joints, blood vessels, viscera, bone) becomes structurally unsound. The specific clinical phenotype depends on which type of collagen is affected and where it is predominantly expressed.
Ehlers-Danlos syndrome is a connective tissue disease associated with the development of inherited cardiac conditions. [1]
2. Epidemiology
- Combined prevalence of all EDS types: approximately 1 in 5,000 (some estimates range from 1/2,500 to 1/5,000)
- Hypermobile EDS (hEDS) is by far the most common subtype, accounting for ~80–90% of cases
- Classical EDS (cEDS) is the second most common (~1 in 20,000–40,000)
- Vascular EDS (vEDS) is rare (~1 in 50,000–250,000) but the most clinically dangerous
- Affects all ethnic groups worldwide with no clear racial predilection
- Most types show no sex predilection (autosomal inheritance), though hEDS is diagnosed more frequently in females, possibly due to hormonal influences on connective tissue laxity and ascertainment bias
- Age of onset: symptoms typically present in childhood or adolescence, but diagnosis is often delayed (median diagnostic delay can be years to decades)
- No large-scale epidemiological data specific to Hong Kong exist
- Awareness and diagnosis rates have been improving with advances in genetic testing available at institutions such as the Clinical Genetic Service at Queen Mary Hospital
- EDS is likely underdiagnosed in the HK population, particularly the hypermobile subtype, which may be dismissed as "benign joint hypermobility"
- In the HK clinical setting, EDS is most relevantly encountered:
Because EDS is almost entirely genetic, the traditional concept of "risk factors" differs from acquired diseases:
- Family history — the single most important risk factor. Most subtypes are autosomal dominant, so an affected parent confers a 50% risk to each offspring
- De novo mutations — approximately 50% of vascular EDS cases arise from new mutations (no family history), making a negative family history insufficient to exclude the diagnosis
- Advanced paternal age — may marginally increase the risk of de novo mutations (as with many autosomal dominant conditions)
There are no modifiable environmental risk factors that "cause" EDS. However, environmental and lifestyle factors influence phenotypic severity (e.g., high-impact sports may worsen joint instability in hEDS).
4. Anatomy and Function of Collagen (The Biological Basis)
To understand EDS from first principles, you must understand collagen biology:
- Collagen (from Greek kolla = glue + gen = producing) is the primary structural protein of the extracellular matrix (ECM)
- There are at least 28 types of collagen identified (types I–XXVIII), but the clinically relevant ones for EDS are:
| Collagen Type | Distribution | Relevant EDS Subtype |
|---|---|---|
| Type I | Bone, skin, tendon, vasculature, cornea, internal organs | Classical EDS (partially) |
| Type III | Blood vessels (especially large arteries), hollow viscera (bowel, uterus), skin | Vascular EDS |
| Type V | Skin, tendon, bone, placenta (regulates Type I collagen fibrillogenesis) | Classical EDS |
| Type XII | Tendons, ligaments, periosteum | Myopathic EDS |
This is crucial because EDS mutations can affect any step:
- EDS mutations disrupt various steps: gene transcription (reduced quantity), triple helix assembly (structural defect), post-translational modification (abnormal cross-linking), or enzymatic processing
- This contrasts with scurvy (vitamin C deficiency), which impairs hydroxylation of proline/lysine → defective collagen cross-linking → similar clinical features (bleeding, skin fragility) but acquired rather than genetic
- Skin: Type I, III, and V collagen provide tensile strength and elasticity. Defective collagen → hyperextensible, fragile skin
- Joints: Collagen in ligaments and joint capsules provides structural constraint. Defective collagen → hypermobility, dislocations
- Blood vessels: Type III collagen is the major structural component of arterial walls, especially in medium and large arteries. Defective Type III collagen → arterial rupture, dissection, aneurysm (vascular EDS)
- GI tract: Type III collagen in bowel wall → risk of bowel perforation (vascular EDS)
- Heart valves: Collagen in valve leaflets → mitral valve prolapse, aortic root dilatation
5. Etiology and Pathophysiology (By Subtype)
The 2017 International Consortium classification (Malfait et al., AJMG Part C) recognises 13 subtypes of EDS. Each has a defined genetic basis. The clinically most important subtypes for exams are:
High Yield: The Big Three EDS Subtypes for Exams
- Hypermobile EDS (hEDS) — most common, no identified gene (clinical diagnosis only)
- Classical EDS (cEDS) — COL5A1/COL5A2 mutations, skin and joint features
- Vascular EDS (vEDS) — COL3A1 mutations, arterial/visceral rupture, the dangerous one
| Subtype | Abbreviation | Gene(s) | Protein | Inheritance | Key Features |
|---|---|---|---|---|---|
| Hypermobile | hEDS | Unknown | Unknown | AD | Generalized joint hypermobility, chronic pain, minimal skin involvement |
| Classical | cEDS | COL5A1, COL5A2 (rarely COL1A1) | Type V collagen (Type I) | AD | Marked skin hyperextensibility, atrophic scarring, generalized joint hypermobility |
| Vascular | vEDS | COL3A1 (rarely COL1A1) | Type III collagen | AD | Thin translucent skin, arterial/intestinal/uterine fragility and rupture, characteristic facial features |
| Kyphoscoliotic | kEDS | PLOD1 (lysyl hydroxylase), FKBP14 | Lysyl hydroxylase 1 | AR | Severe muscle hypotonia at birth, progressive kyphoscoliosis, ocular fragility |
| Arthrochalasia | aEDS | COL1A1, COL1A2 | Type I collagen | AD | Congenital bilateral hip dislocation, severe generalized joint hypermobility |
| Dermatosparaxis | dEDS | ADAMTS2 | Procollagen I N-proteinase | AR | Extreme skin fragility, sagging redundant skin |
| Classical-like | clEDS | TNXB | Tenascin-X | AR | Skin hyperextensibility, easy bruising, generalized joint hypermobility |
| Spondylodysplastic | spEDS | B4GALT7, B3GALT6, SLC39A13 | Various | AR | Short stature, muscle hypotonia, bowing of limbs |
| Musculocontractural | mcEDS | CHST14, DSE | Dermatan sulfate biosynthesis enzymes | AR | Congenital contractures, characteristic craniofacial features |
| Myopathic | mEDS | COL12A1 | Type XII collagen | AD or AR | Congenital muscle hypotonia, proximal joint contractures |
| Periodontal | pEDS | C1R, C1S | Complement C1r/C1s | AD | Severe, early-onset periodontitis, pretibial plaques |
| Cardiac-valvular | cvEDS | COL1A2 (biallelic) | Type I collagen (complete absence of pro-α2(I) chain) | AR | Severe progressive cardiac valvular problems (aortic, mitral) |
| Brittle cornea syndrome | BCS | ZNF469, PRDM5 | Zinc finger protein 469 / PR domain 5 | AR | Thin cornea, keratoconus, keratoglobus, blue sclerae |
EDS inheritance patterns relevant to inherited cardiac conditions: [1]
- Autosomal dominant inheritance: hypermobile, classical, and vascular EDS
- Autosomal recessive inheritance: kyphoscoliotic EDS
Detailed Pathophysiology by Key Subtypes
- Genetic basis: Unknown — this is the only EDS subtype with no identified causative gene as of 2025–2026. Likely oligogenic or polygenic
- Pathophysiology: Presumed defect in ECM composition or cell-matrix signalling that leads to ligamentous laxity and altered proprioception
- Why no gene? The phenotype likely results from multiple interacting genetic variants rather than a single-gene defect. This is why hEDS is a clinical diagnosis using the 2017 diagnostic criteria (Beighton score + additional criteria)
- Key clinical consequence: Chronic widespread musculoskeletal pain (not just hypermobility) — likely from repetitive microtrauma to lax joints, central sensitisation, and autonomic dysfunction
- Gene: COL5A1 or COL5A2 mutations (>90% of cases)
- Pathophysiology:
- Type V collagen acts as a regulatory collagen — it controls the initiation and diameter of Type I collagen fibril assembly
- When Type V collagen is deficient or structurally abnormal, Type I collagen fibrils become irregular in diameter and cross-section ("cauliflower" appearance on electron microscopy)
- This directly explains:
- Skin hyperextensibility (abnormal fibril architecture → decreased tensile strength)
- Atrophic ("cigarette-paper") scarring (poor wound healing due to defective collagen deposition)
- Easy bruising (fragile dermal blood vessels)
- Gene: COL3A1 mutations (~95%), rarely COL1A1 (specific arginine-to-cysteine substitutions)
- Pathophysiology:
- Type III collagen is the major structural collagen of blood vessel walls (especially the tunica media of medium and large arteries), bowel wall, and uterine wall
- Mutations lead to either:
- Quantitative deficiency: haploinsufficiency (reduced amount of normal Type III collagen) — better prognosis
- Dominant-negative effect: structurally abnormal Type III collagen molecules incorporate into and disrupt the entire collagen trimer (since collagen is a homotrimer of three α1(III) chains, one abnormal chain poisons the whole molecule) — worse prognosis
- Weakened vessel walls → spontaneous arterial dissection, aneurysm, and rupture (especially medium-sized arteries: iliac, renal, splenic, mesenteric, but also aorta)
- Weakened bowel wall → spontaneous bowel perforation (usually sigmoid colon)
- Weakened uterine wall → uterine rupture during pregnancy (extremely high maternal mortality)
Why Vascular EDS is Specifically Dangerous
In other EDS types, the primary morbidity is musculoskeletal (joint dislocations, chronic pain). In vEDS, the defective collagen is preferentially expressed in blood vessels and hollow organs, so the first presentation may be a catastrophic vascular event (arterial rupture, bowel perforation) in a young person, often with no prior diagnosis. The median survival without treatment is approximately 50 years, with death usually from arterial rupture.
- Gene: PLOD1 — encodes lysyl hydroxylase 1 (LH1), an enzyme critical for post-translational modification of collagen
- Pathophysiology:
- LH1 hydroxylates lysine residues in collagen → hydroxylysine is essential for stable collagen cross-linking
- Deficiency → under-crosslinked collagen → generalized connective tissue weakness
- Progressive kyphoscoliosis (from birth), severe muscle hypotonia, ocular fragility (risk of globe rupture)
- This is autosomal recessive [1]
6. Classification
As detailed in the table above — 13 subtypes.
- Autosomal dominant: hEDS, cEDS, vEDS, aEDS, pEDS, mEDS (some)
- Autosomal recessive: kEDS, dEDS, clEDS, spEDS, mcEDS, cvEDS, BCS, mEDS (some)
| Category | Subtypes | Dominant Feature |
|---|---|---|
| Joint-predominant | hEDS, aEDS | Joint hypermobility, dislocations |
| Skin-predominant | cEDS, dEDS, clEDS | Skin hyperextensibility, fragility, scarring |
| Vascular-predominant | vEDS, cvEDS | Arterial and visceral fragility |
| Musculoskeletal/Spinal | kEDS, spEDS, mEDS | Kyphoscoliosis, hypotonia, skeletal deformity |
| Periodontal | pEDS | Early-onset periodontitis |
| Ocular | BCS, kEDS | Corneal/scleral fragility |
You may still see the old Roman numeral system in older textbooks/exam papers:
| Old Classification | Current Name |
|---|---|
| Type I (Gravis) | Classical EDS (severe form) |
| Type II (Mitis) | Classical EDS (mild form) |
| Type III | Hypermobile EDS |
| Type IV | Vascular EDS |
| Type VI | Kyphoscoliotic EDS |
| Type VIIA/B | Arthrochalasia EDS |
| Type VIIC | Dermatosparaxis EDS |
Ehlers-Danlos type IV is specifically the vascular subtype associated with aortic aneurysm and dissection. [2][4]
7. Clinical Features
The clinical features of EDS depend on the subtype. However, there are overlapping features across subtypes. I will organise them by symptoms and signs, with the pathophysiological basis explained inline.
7.1 Symptoms
-
Recurrent joint dislocations and subluxations (especially shoulders, patella, TMJ, fingers, hips)
- Why? Defective collagen in ligaments and joint capsules → inability to constrain joints within normal range → repetitive instability
- Most prominent in hEDS and cEDS
- In arthrochalasia EDS: congenital bilateral hip dislocation is the hallmark (occurs at birth due to severe ligamentous laxity)
-
Chronic widespread musculoskeletal pain
- Why? Multifactorial: repetitive joint microtrauma from instability → local inflammation → central pain sensitisation → chronic pain syndrome
- Pain is often disproportionate to objective findings — a source of diagnostic confusion
- Pain is the primary source of disability in hEDS
-
Easy fatigue
- Why? Muscles must work harder to compensate for unstable joints → increased energy expenditure → fatigue. Also associated with dysautonomia (see below)
-
Back pain
- Why? Spinal instability (hypermobile intervertebral joints), kyphoscoliosis (especially kEDS), dural ectasia
-
Easy bruising ("I bruise very easily, doctor")
- Why? Fragile dermal blood vessels (collagen is a structural component of vessel walls) → minor trauma causes extravasation → hyperelasticity of skin is a physical examination clue in bleeding tendency workup [3]
- Important: easy bruising is a prominent feature of vEDS and cEDS, and may be the presenting complaint that triggers haematological referral
-
Poor wound healing / abnormal scarring
- Why? Defective collagen deposition during wound repair → wounds take longer to heal, and healed wounds form atrophic, widened, papyraceous ("cigarette-paper") scars
- Classical EDS is particularly associated with "fish-mouth" gaping wounds that split open with minimal trauma
-
Skin that "stretches too much"
- Why? Defective collagen fibril architecture → reduced tensile strength → skin can be stretched far beyond normal limits (but recoils on release, distinguishing from cutis laxa where skin hangs loosely)
-
Palpitations, presyncope, syncope (especially in hEDS)
- Why? Associated dysautonomia (particularly postural orthostatic tachycardia syndrome, POTS) — connective tissue laxity affects venous compliance → excessive venous pooling on standing → reflex tachycardia and reduced cerebral perfusion
-
Chest pain (vEDS)
-
Sudden collapse / sudden death (vEDS)
- Why? Spontaneous arterial rupture (e.g., iliac, splenic, aortic) → massive internal haemorrhage
-
Chronic abdominal pain, bloating, constipation/diarrhoea (especially hEDS)
- Why? Connective tissue laxity in bowel wall → dysmotility; visceral hypersensitivity; overlap with functional GI disorders (IBS-like presentation)
-
Acute abdomen (vEDS)
- Why? Spontaneous bowel perforation (usually sigmoid colon) → peritonitis
- Also: spontaneous splenic rupture
-
Dental problems: early tooth loss, periodontal disease (especially pEDS where aggressive periodontitis occurs in childhood/adolescence due to complement-related defects)
-
Visual symptoms: myopia (in some subtypes), risk of retinal detachment (kEDS), corneal thinning/rupture (BCS)
-
Gynaecological/Obstetric: menorrhagia (bleeding tendency), pelvic organ prolapse (ligamentous laxity), preterm premature rupture of membranes, uterine rupture in pregnancy (vEDS)
-
Headaches: cervicogenic headaches (from cervical instability), migraines (associated with dysautonomia)
7.2 Signs
-
Skin hyperextensibility
- Tested by gently pulling the skin on the dorsum of the hand, volar forearm, or neck
- Positive if skin stretches beyond the normal range (>1.5 cm on dorsum of hand, >3 cm on neck, >3 cm on volar forearm) and recoils back (distinguishing from cutis laxa)
- Pathophysiological basis: defective collagen fibril architecture → reduced mechanical restraint
-
Velvety, soft ("doughy") skin texture
- Why? Altered collagen-elastin ratio in dermis
- Characteristic of cEDS
-
Atrophic scarring ("cigarette-paper" or "papyraceous" scars)
- Typically over bony prominences (shins, knees, elbows, forehead) where minor trauma is frequent
- Why? Defective collagen deposition during healing
-
Molluscoid pseudotumours
- Fleshy, scar-associated lesions over pressure points (elbows, knees)
- Why? Fat herniation through defective dermal collagen at scarred sites
-
Subcutaneous spheroids
- Small, hard, mobile nodules palpable under skin (often forearms, shins)
- Why? Calcified fat lobules from minor subcutaneous haemorrhage that organise
-
Easy bruising (ecchymoses)
- Often extensive and disproportionate to the degree of trauma
- Why? Fragile dermal vasculature
-
Thin, translucent skin (especially vEDS)
- Venous pattern visible through skin, especially on chest, abdomen, and extremities
- Why? Deficiency of Type III collagen in dermis → reduced dermal thickness
-
Striae (stretch marks) at a young age, without the usual precipitants (pregnancy, obesity, steroid use)
- Generalised joint hypermobility (GJH)
- Assessed using the Beighton Score (0–9 scale):
| Manoeuvre | Points (per side) |
|---|---|
| Passive dorsiflexion of 5th MCP > 90° | 1 per hand |
| Passive apposition of thumb to volar forearm | 1 per hand |
| Hyperextension of elbow > 10° | 1 per arm |
| Hyperextension of knee > 10° | 1 per leg |
| Forward flexion of trunk with knees extended, palms flat on floor | 1 |
| Total | /9 |
-
Beighton score cutoffs for GJH:
- Prepubertal children/adolescents: ≥ 6
- Adults up to age 50: ≥ 5
- Adults > 50: ≥ 4
-
Joint subluxation/dislocation (may be demonstrable on examination)
-
Positive "prayer sign" or "reverse prayer sign" (demonstrating hyperextensibility)
-
Pes planus (flat feet)
- Why? Ligamentous laxity → loss of arch support
-
Temporomandibular joint (TMJ) dysfunction
- Clicking, locking, subluxation of the jaw
-
Mitral valve prolapse (MVP)
- Mid-systolic click ± late systolic murmur on auscultation
- Why? Myxomatous degeneration of mitral valve leaflets (collagen-deficient leaflets become redundant and floppy)
- Common in hEDS and cEDS
-
Aortic root dilatation
- May be detected as a widened mediastinum on CXR or on echocardiography
- Why? Defective collagen (especially Type III) in the aortic wall → progressive dilatation of the aortic root ± ascending aorta
- Most relevant in vEDS but can occur in other subtypes
- This is a shared cardiac manifestation with Marfan syndrome (where aortic root dilatation → aortic regurgitation) [1]
-
Aortic regurgitation (AR) murmur
- Early diastolic decrescendo murmur, best heard at the left sternal border in the sitting-up position
- Why? Aortic root dilatation → failure of aortic valve leaflet coaptation
-
Arterial bruits (in vEDS — may indicate dissection or aneurysm)
-
BP discrepancy between arms (in dissection — same principle as in aortic dissection of any cause)
- Characteristic facial appearance in vascular EDS:
- Thin, pinched nose
- Thin lips
- Hollow cheeks
- Prominent eyes (due to decreased periorbital subcutaneous fat)
- Lobeless ears
- Why? Deficiency of Type III collagen in subcutaneous tissues → reduced facial soft tissue volume
-
Piezogenic papules (small fat herniations through the heel fascia visible on standing)
- Why? Defective connective tissue in plantar fascia allows fat lobule herniation
-
Dental crowding / high arched palate (overlaps with Marfan syndrome)
-
Kyphoscoliosis (especially kEDS — progressive, severe)
- Why? Defective collagen in paravertebral ligaments and intervertebral discs → progressive spinal curvature
-
Muscle hypotonia (kEDS, mEDS)
- Why? Connective tissue in the endomysium and perimysium of muscle is collagen-dependent → defective collagen → impaired force transmission
-
Blue sclerae (BCS, some kEDS cases)
- Why? Thinned scleral collagen allows underlying uveal pigment to show through (same mechanism as in osteogenesis imperfecta)
-
Hernia (inguinal, umbilical, incisional)
- Why? Defective collagen in abdominal wall fascial layers → inability to withstand intra-abdominal pressure
-
Rectal prolapse, uterine prolapse
- Why? Connective tissue weakness in pelvic floor support structures
This is high-yield for exams — the conditions that cluster together in the "inherited connective tissue diseases with cardiac manifestations":
| Feature | EDS (general/hEDS/cEDS) | Vascular EDS | Marfan Syndrome | Loeys-Dietz Syndrome | Osteogenesis Imperfecta |
|---|---|---|---|---|---|
| Primary protein | Collagen V (cEDS), unknown (hEDS) | Collagen III | Fibrillin-1 | TGF-β receptor | Collagen I |
| Joint hypermobility | +++ | + (limited) | ++ | ++ | ++ |
| Skin hyperextensibility | +++ (cEDS) | ± (thin/translucent instead) | ± striae | ± | Thin |
| Aortic root dilatation | ± (mild) | + (but also medium arteries) | +++ (cardinal feature) | +++ | Rare |
| Lens subluxation | No | No | +++ (upward) | No | No |
| Arterial rupture | Rare | +++ (cardinal feature) | Rare (dissection > rupture) | + | No |
| Bowel perforation | Rare | +++ | No | ± | No |
| Blue sclerae | BCS subtype | No | No | ± | +++ |
| Fractures | No | No | No | No | +++ |
| Bifid uvula/cleft palate | No | No | No | +++ | No |
| Arterial tortuosity | No | No | No | +++ | No |
High Yield: Comparing Inherited Cardiac Connective Tissue Diseases
The connective tissue diseases associated with inherited cardiac conditions include: [1]
- Marfan syndrome (AD — FBN1 — aortic root dilatation, MVP)
- Ehlers-Danlos syndrome (AD for vascular/classical/hypermobile; AR for kyphoscoliotic — arterial and visceral fragility in vEDS)
- Loeys-Dietz syndrome (AD — TGFBR1/2 — aggressive aortic aneurysm, arterial tortuosity, bifid uvula)
- Familial thoracic aortic aneurysm and dissection (AD)
- Bicuspid aortic valvulopathy (AD with incomplete penetrance and variable expressivity)
EDS, particularly vEDS and cEDS, can present as a bleeding disorder because:
- Defective collagen in vessel walls → impaired primary haemostasis (platelets adhere to subendothelial collagen as the first step of haemostasis → defective collagen → impaired platelet adhesion)
- Capillary/vessel fragility → easy bruising, mucosal bleeding
- Standard coagulation tests (PT, aPTT) are typically normal — the problem is in the vessel wall, not the coagulation cascade
- On physical examination for bleeding tendency: hyperelasticity of skin indicates Ehlers-Danlos syndrome [3]
- Telangiectasiae around lips/fingertips indicate HHT (hereditary haemorrhagic telangiectasia) — this is a key differential [3]
Exam pearl: A young person with unexplained easy bruising + normal coagulation tests + hyperextensible skin on examination → think EDS. The bleeding time (or PFA-100) may be prolonged due to defective collagen-platelet interaction, but platelet count and PT/aPTT are normal.
Ehlers-Danlos syndrome (especially vascular type) is a recognised cause of: [2][4][5]
- Aortic aneurysm (thoracic and abdominal)
- Aortic dissection
In the context of abdominal aortic aneurysm (AAA): [4]
- Genetic causes of AAA include Marfan's syndrome and Ehlers-Danlos type IV
- The pathology involves loss of elastin and smooth muscle cells, disruption of extracellular matrix, deposition of adventitial collagen, thickening, and inflammatory infiltrate
In the context of aortic dissection: [2][5]
- The underlying pathology permitting dissection is medial collagen and elastin degeneration
- Genetic connective tissue diseases (Marfan syndrome, Ehlers-Danlos, Loeys-Dietz) are among the causes alongside hypertension (80%), bicuspid aortic valve, and trauma
High Yield Summary
Ehlers-Danlos Syndrome — Key Points for HKUMed Summative Exams:
- Definition: Group of heritable connective tissue disorders due to defective collagen (various types)
- Most common subtype: Hypermobile EDS (hEDS) — no identified gene, clinical diagnosis
- Most dangerous subtype: Vascular EDS (vEDS) — COL3A1 → Type III collagen deficiency → arterial rupture, bowel perforation, uterine rupture
- Classical EDS: COL5A1/COL5A2 → atrophic scarring, skin hyperextensibility, joint hypermobility
- Inheritance: Mostly AD (hEDS, cEDS, vEDS); some subtypes AR (kEDS, dEDS)
- Clinical triad: Joint hypermobility + Skin hyperextensibility + Tissue fragility
- Beighton Score: Used to assess generalised joint hypermobility (0–9)
- Cardiac manifestations: MVP, aortic root dilatation (shared with Marfan), arterial aneurysm/dissection (especially vEDS)
- Bleeding tendency: Normal PT/aPTT, defective collagen → impaired vessel wall integrity and platelet adhesion → easy bruising
- EDS is listed as a connective tissue disease associated with inherited cardiac conditions (along with Marfan, Loeys-Dietz, familial thoracic aortic aneurysm/dissection, and bicuspid aortic valvulopathy) [1]
- EDS type IV (vascular) is a genetic cause of AAA alongside Marfan syndrome [4]
- EDS is a cause of aortic dissection alongside hypertension, Marfan syndrome, and Loeys-Dietz syndrome [2][5]
Active Recall - Ehlers-Danlos Syndrome
[1] Lecture slides: GC 069. Inherited Cardiac conditions.pdf; Block A - Inherited Cardiac conditions.pdf [2] Senior notes: Block A - Sudden severe chest pain_ acute myocardial infarction; aortic dissection.pdf [3] Senior notes: Ryan Ho Haemtology.pdf (Section 4.1.2 - Approach to Bleeding Disorders) [4] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf [5] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf; MBBS Final MB (Surgery) (Felix PY Lai).pdf
Differential Diagnosis of Ehlers-Danlos Syndrome
Before listing differentials, understand the core problem. EDS presents with a constellation of features — joint hypermobility, skin changes, tissue fragility, bleeding tendency, vascular events — that individually overlap with many other conditions. The differential diagnosis therefore depends on which clinical presentation brings the patient to medical attention:
- A child/adolescent with generalised joint hypermobility → DDx centres on other causes of hypermobility
- A young adult with easy bruising / bleeding tendency → DDx centres on haematological and vascular causes
- A young patient with spontaneous arterial rupture or dissection → DDx centres on inherited aortopathies / connective tissue diseases
- A patient with skin hyperextensibility and abnormal scarring → DDx centres on other inherited skin/connective tissue disorders
The DDx is therefore best organised by presenting clinical scenario.
When a patient presents with generalised joint hypermobility (high Beighton score), the question is: is this EDS, or something else?
| Condition | Key Distinguishing Features from hEDS | Why it can mimic EDS |
|---|---|---|
| Benign/Generalised Joint Hypermobility Spectrum Disorder (G-HSD) | Hypermobility present, but does NOT meet the full 2017 hEDS criteria (lacks the systemic features such as skin involvement, positive family history, or musculoskeletal complications). No chronic pain syndrome or functional impairment. | Shares joint hypermobility; the distinction is essentially one of severity and associated features. G-HSD is the "milder" end of the hypermobility spectrum |
| Marfan Syndrome (MFS) | Tall stature with long thin limbs (arm span > height), arachnodactyly (positive thumb and wrist sign), pectus deformity, lens subluxation (usually upward), aortic root dilatation at the sinus of Valsalva. [6] FBN1 mutation (fibrillin-1). Diagnosed by revised Ghent nosology (aortic criterion + ectopia lentis, or aortic criterion + FBN1, or systemic score ≥ 7) [7] | Marfan patients have joint hypermobility and pes planus (overlap with EDS). Both can have MVP and aortic root dilatation. Key differentiator: ectopia lentis (lens subluxation) is virtually pathognomonic for Marfan and does NOT occur in EDS. Marfan patients tend to be tall and thin with disproportionately long limbs; EDS patients do not have a Marfanoid habitus. |
| Loeys-Dietz Syndrome (LDS) | Autosomal dominant, mutations in TGFBR1/TGFBR2 [1]. Hallmark triad: arterial tortuosity/aneurysms, hypertelorism, bifid uvula or cleft palate. More aggressive aortic disease than Marfan (dissection at smaller aortic diameters). | Shares joint hypermobility, skin translucency, easy bruising. Key differentiator: bifid uvula/cleft palate and widespread arterial tortuosity are specific to LDS and not seen in EDS |
| Osteogenesis Imperfecta (OI) | Blue sclerae (in types I and IV), recurrent fractures from minimal trauma, dentinogenesis imperfecta, short stature (severe types). Type I collagen defect (COL1A1/COL1A2). | OI patients can have joint hypermobility (especially Type I OI). Key differentiator: recurrent low-trauma fractures and blue sclerae point to OI rather than EDS. Skin hyperextensibility is minimal in OI. |
| Stickler Syndrome | Vitreoretinal degeneration (risk of retinal detachment), sensorineural hearing loss, midface hypoplasia, Pierre-Robin sequence, early-onset osteoarthritis. COL2A1, COL11A1/A2 mutations. | Shares joint hypermobility. Key differentiator: prominent ocular findings (myopia, vitreous degeneration, retinal detachment) combined with midface hypoplasia and hearing loss distinguish Stickler from EDS. |
| Down Syndrome | Trisomy 21. Characteristic facial features, intellectual disability, cardiac defects (AVSD). | Ligamentous laxity is common in Down syndrome but distinguished easily by the syndromic phenotype |
| Cleidocranial Dysplasia | RUNX2 mutation. Absent/hypoplastic clavicles, delayed closure of fontanelles, dental abnormalities. | Joint hypermobility is present but the skeletal phenotype is distinctive |
High Yield: EDS vs Marfan — The Examiner's Favourite Comparison
Both EDS and Marfan are connective tissue diseases associated with inherited cardiac conditions [1]. The critical distinguishing features:
| Feature | EDS | Marfan |
|---|---|---|
| Primary protein | Collagen (various types) | Fibrillin-1 |
| Skin | Hyperextensible, velvety, atrophic scars | Striae atrophicae, but no hyperextensibility |
| Lens | Normal | Ectopia lentis (upward and temporal displacement) [6] |
| Aortic root | Mild dilatation (except vEDS → medium artery rupture) | Aortic root dilatation at the sinus of Valsalva (cardinal feature) [7] |
| Body habitus | Normal proportions | Tall, long limbs, arm span > height, arachnodactyly [6] |
| Thumb/Wrist sign | Usually negative | Positive (arachnodactyly) [6] |
| Wound healing | Poor, atrophic scars | Normal |
| Condition | Key Distinguishing Features | Why it can mimic EDS |
|---|---|---|
| Cutis Laxa ("loose skin") | Skin hangs in loose, redundant folds and does NOT recoil after stretching (key difference — in EDS, skin recoils). Elastic fibre defect (elastin, fibulin, LTBP4). Can be AD, AR, or X-linked. Associated with emphysema, diverticula, herniae, aortic root dilatation. | Both have abnormal skin. Key differentiator: in cutis laxa the skin hangs and does not recoil; in EDS the skin stretches far but snaps back. This is the single most important physical examination distinction. |
| Pseudoxanthoma Elasticum (PXE) | "Plucked chicken skin" — yellowish papules on neck, axillae, groin (sites of flexural skin). Elastic fibre calcification and fragmentation (ABCC6 mutation). Angioid streaks on fundoscopy. GI bleeding from mucosal arterial fragility. | Skin changes and vascular fragility overlap. Key differentiator: PXE produces yellowish papular skin lesions at flexural sites + angioid streaks, which are absent in EDS. |
| Focal Dermal Hypoplasia (Goltz Syndrome) | X-linked dominant. Atrophic skin lesions, fat herniation through skin, skeletal anomalies, ocular defects. | Skin fragility and fat herniation resemble EDS molluscoid pseudotumours. Syndromic features distinguish it. |
| De Barsy Syndrome | Cutis laxa + corneal clouding + intellectual disability. AR. | Loose skin and joint hypermobility can mimic EDS |
| Acquired cutis laxa | Secondary to inflammatory skin diseases, drug reactions (penicillamine), or lymphoproliferative disorders. Late onset. No family history. | Must be distinguished from inherited connective tissue disease |
This is a particularly important clinical scenario because EDS may first present to a haematologist with easy bruising and normal coagulation screen.
On physical examination for bleeding tendency: hyperelasticity of skin indicates Ehlers-Danlos syndrome; telangiectasiae around lips/fingertips indicate HHT [3][8]
| Condition | Key Distinguishing Features | Why it can mimic EDS |
|---|---|---|
| von Willebrand Disease (vWD) | Most common inherited bleeding disorder. Mucocutaneous bleeding (epistaxis, menorrhagia, post-dental extraction bleeding). Prolonged PFA-100/bleeding time. Low vWF activity/antigen. aPTT may be prolonged (vWF carries Factor VIII). | Easy bruising + mucocutaneous bleeding overlaps with EDS. Key differentiator: vWD has abnormal vWF function assay and often a prolonged aPTT. In EDS, vWF is normal and aPTT/PT are normal — the defect is in vessel wall collagen, not a coagulation cascade problem. |
| Platelet function disorders (e.g., Bernard-Soulier, Glanzmann thrombasthenia) [9] | Mucocutaneous bleeding pattern, prolonged bleeding time/PFA-100. Bernard-Soulier: giant platelets + thrombocytopenia + defective GPIb-IX-V (vWF receptor). Glanzmann: normal platelet count + defective GPIIb/IIIa (fibrinogen receptor). | Bleeding pattern similar to EDS. Key differentiator: platelet aggregation studies are abnormal in these disorders. In EDS, platelet function is typically normal (although the collagen-platelet interaction may be impaired secondarily). |
| Immune Thrombocytopenia (ITP) | Low platelet count on CBC. Petechiae, mucosal bleeding. | Easy bruising overlaps. Key differentiator: ITP has thrombocytopenia; EDS has normal platelet count. |
| Hereditary Haemorrhagic Telangiectasia (HHT / Osler-Weber-Rendu) | AD. Recurrent epistaxis, GI bleeding. Telangiectasiae around lips and fingertips [3]. Pulmonary and hepatic AVMs. | Mucosal bleeding and easy bruising overlap. Key differentiator: visible telangiectasiae on lips/fingers/tongue in HHT vs. skin hyperelasticity in EDS. |
| Scurvy (Vitamin C deficiency) | Perifollicular haemorrhage, corkscrew hairs, gingival swelling/bleeding, petechiae, poor wound healing. Dietary history reveals severe deficiency. | Remarkably similar to EDS — both involve defective collagen (scurvy from inadequate hydroxylation, EDS from genetic defect). Poor wound healing and bleeding are shared. Key differentiator: scurvy is acquired (dietary history), responds to vitamin C supplementation, and presents with perifollicular haemorrhage (specific to scurvy). |
| Non-accidental injury (child abuse) | Multiple bruises of different ages in unusual locations (ears, neck, buttocks, trunk). Inconsistent history. Fearful child. | In a young child with extensive bruising and normal coagulation, both EDS and child abuse must be considered. This is a medicolegal red flag — EDS must be formally excluded before attributing bruising to abuse, and vice versa. |
Exam Pearl: EDS vs Bleeding Disorders
The bleeding in EDS is a vessel wall defect (defective collagen → fragile capillaries → extravasation from minimal trauma), NOT a coagulation cascade or platelet defect. Therefore:
- Platelet count: Normal
- PT / aPTT: Normal
- Bleeding time / PFA-100: May be prolonged (because platelets adhere to subendothelial collagen as the first step of primary haemostasis — defective collagen impairs this adhesion)
- Specific clotting factor assays: Normal
This pattern of "bleeding with normal coagulation screen" should prompt examination of the skin for hyperelasticity [3].
This is the most dangerous clinical scenario — a young person presents with spontaneous arterial dissection, aneurysm, or rupture, or is found to have aortic root dilatation.
The causes of aortic dissection include: [2][5][10]
- Coexisting hypertension (80%)
- Genetic diseases: Marfan syndrome, Familial aortic aneurysm/dissection, Ehlers-Danlos, Loeys-Dietz aneurysm syndrome
- Bicuspid aortic valve
- Trauma
Genetic causes of abdominal aortic aneurysm include Marfan's and Ehlers-Danlos type IV [4]
| Condition | Gene / Protein | Key Distinguishing Features | Aortic Pathology Pattern |
|---|---|---|---|
| Vascular EDS (vEDS) | COL3A1 / Type III collagen | Thin, translucent skin; characteristic facies (thin nose, thin lips, hollow cheeks, prominent eyes); easy bruising; no lens subluxation; bowel/uterine rupture | Medium-sized artery rupture predominates (iliac, renal, splenic); aortic dissection/rupture less common but occurs |
| Marfan Syndrome | FBN1 / Fibrillin-1 | Tall, thin, arachnodactyly, ectopia lentis (upward), aortic root dilatation, MVP, pectus deformity, dural ectasia [6][7] | Aortic root dilatation at the sinus of Valsalva → AR → dissection [7] |
| Loeys-Dietz Syndrome (LDS) | TGFBR1 / TGFBR2 | Bifid uvula or cleft palate, hypertelorism, arterial tortuosity, cervical spine instability, club feet. More aggressive aortic course than Marfan (dissection at smaller diameters) [1] | Widespread arterial aneurysms and tortuosity throughout the arterial tree |
| Familial Thoracic Aortic Aneurysm and Dissection (FTAAD) | Various (ACTA2, MYH11, TGFBR1/2, SMAD3, others) | Autosomal dominant. Isolated aortic disease without systemic connective tissue features (no hypermobility, no skin changes, no lens problems) [1] | Thoracic aortic aneurysm and dissection; can also have livedo reticularis, iris flocculi, PDA (ACTA2-related) |
| Bicuspid Aortic Valvulopathy | Various / structural | Bicuspid aortic valve on echo, may cause AS or AR, associated aortopathy with ascending aortic dilatation. AD with incomplete penetrance and variable expressivity [1] | Ascending aortopathy; risk of dissection |
| Turner Syndrome | 45,X | Female. Short stature, webbed neck, wide-spaced nipples, streak gonads, coarctation of aorta, bicuspid aortic valve | Aortic dissection (especially in context of coarctation, bicuspid valve, or hypertension) |
| Fibromuscular Dysplasia (FMD) | Sporadic / polygenic | Young to middle-aged women. "String of beads" appearance on angiography of renal or carotid arteries. Causes renovascular hypertension, cervical artery dissection. | Dissection of medium-sized arteries (renal, carotid, vertebral) but not typically aorta |
High Yield: The Inherited Aortopathy / Connective Tissue Disease Family
The connective tissue diseases associated with inherited cardiac conditions and their inheritance patterns are: [1]
- Marfan syndrome — Autosomal dominant
- Ehlers-Danlos syndrome — Autosomal dominant (hypermobile, classical, vascular EDS); Autosomal recessive (kyphoscoliotic EDS)
- Loeys-Dietz syndrome — Autosomal dominant
- Familial thoracic aortic aneurysm and dissection — Autosomal dominant
- Bicuspid aortic valvulopathy — Autosomal dominant with incomplete penetrance and variable expressivity
When you have established that the patient has EDS, the next question is: which subtype? This matters enormously for prognosis and management (vEDS carries life-threatening risk; hEDS does not).
| Feature | Hypermobile EDS | Classical EDS | Vascular EDS | Kyphoscoliotic EDS |
|---|---|---|---|---|
| Joint hypermobility | +++ (generalised) | ++ | ± (usually limited to small joints) | ++ |
| Skin hyperextensibility | ± (mild, velvety) | +++ (marked, doughy) | − (thin/translucent instead) | + |
| Atrophic scarring | − or ± | +++ | − | ± |
| Easy bruising | + | ++ | +++ | + |
| Arterial events | − | − | +++ (life-threatening) | ± (rare) |
| Bowel perforation | − | − | +++ | − |
| Kyphoscoliosis | ± (mild) | ± (mild) | − | +++ (progressive from birth) |
| Muscle hypotonia | − | − | − | +++ (neonatal) |
| Ocular fragility | − | − | − | ++ (globe rupture risk) |
| Inheritance | AD | AD | AD | AR [1] |
| Gene | Unknown | COL5A1/A2 | COL3A1 | PLOD1 |
| Condition | Relationship to EDS |
|---|---|
| Postural Orthostatic Tachycardia Syndrome (POTS) | Highly comorbid with hEDS (30–80% of hEDS patients). Not a DDx — it coexists. Connective tissue laxity → excessive venous pooling → reflex tachycardia on standing. |
| Mast Cell Activation Syndrome (MCAS) | Increasingly recognised comorbidity with hEDS. Flushing, urticaria, GI symptoms. Not a DDx but a co-existing condition. |
| Functional GI Disorders (IBS) | GI dysmotility in hEDS can be labelled as IBS. EDS is the underlying cause. |
| Fibromyalgia | Chronic widespread pain in hEDS can be misdiagnosed as fibromyalgia. Both may coexist. |
| Chronic Fatigue Syndrome | Fatigue in hEDS may be attributed to CFS. Look for joint hypermobility and skin signs. |
| Rheumatoid Arthritis | Multiple joint complaints in EDS may be initially misdiagnosed as RA. Key differentiator: RA is an inflammatory arthropathy (swollen, warm joints, morning stiffness > 1 hour, elevated inflammatory markers, erosions on XR, RF/anti-CCP positive). EDS joints are hypermobile and unstable but not inflamed. |
| Systemic Lupus Erythematosus (SLE) | Joint hypermobility in SLE (Jaccoud's arthropathy — reducible deformities) can mimic EDS. Key differentiator: SLE has multisystem inflammation (malar rash, serositis, nephritis, cytopenias), ANA positivity, and specific antibodies (anti-dsDNA, anti-Smith) [11] |
| DDx | The ONE feature that distinguishes it from EDS |
|---|---|
| Marfan syndrome | Ectopia lentis (upward lens subluxation) [6] |
| Loeys-Dietz syndrome | Bifid uvula / cleft palate + arterial tortuosity [1] |
| Osteogenesis imperfecta | Recurrent fractures + blue sclerae |
| Cutis laxa | Skin does NOT recoil (hangs loosely) |
| Pseudoxanthoma elasticum | Yellowish papular skin at flexures + angioid streaks |
| von Willebrand disease | Abnormal vWF assay ± prolonged aPTT |
| HHT | Telangiectasiae on lips/fingertips [3] |
| Scurvy | Dietary history + perifollicular haemorrhage |
| Fibromuscular dysplasia | "String of beads" on angiography; medium artery dissection |
High Yield Summary — Differential Diagnosis of EDS
- Joint hypermobility DDx: Benign hypermobility spectrum disorder (milder), Marfan (tall + lens subluxation), Loeys-Dietz (bifid uvula + arterial tortuosity), Osteogenesis Imperfecta (fractures + blue sclerae), Stickler (vitreoretinal + hearing loss)
- Skin DDx: Cutis laxa (skin does NOT recoil), PXE (yellowish papules + angioid streaks)
- Bleeding DDx: vWD (abnormal vWF assay), platelet disorders (abnormal aggregation), HHT (telangiectasiae), scurvy (perifollicular haemorrhage), child abuse (inconsistent history)
- Aortic/Vascular DDx: Marfan, Loeys-Dietz, FTAAD, Bicuspid aortic valvulopathy [1] — the inherited aortopathy family
- Physical examination clue: skin hyperelasticity → think EDS; telangiectasiae on lips/fingertips → think HHT [3]
- EDS and Marfan are both connective tissue diseases associated with inherited cardiac conditions [1]
- EDS is a recognised genetic cause of aortic dissection alongside Marfan, Loeys-Dietz, and FTAAD [2][5][10]
Active Recall - Differential Diagnosis of EDS
References
[1] Lecture slides: GC 069. Inherited Cardiac conditions.pdf; Block A - Inherited Cardiac conditions.pdf [2] Senior notes: Block A - Sudden severe chest pain_ acute myocardial infarction; aortic dissection.pdf [3] Senior notes: Ryan Ho Haemtology.pdf (Section 4.1.2 - Approach to Bleeding Disorders) [4] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf [5] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf; MBBS Final MB (Surgery) (Felix PY Lai).pdf [6] Senior notes: Adrian Lui Pediatrics Notes.pdf (Marfan syndrome section) [7] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Marfan syndrome diagnosis) [8] Senior notes: Adrian Lui Pediatrics Notes.pdf (Bleeding tendency physical examination) [9] Senior notes: Block A - Abnormal bleeding after tooth extraction_ bleeding tendency; thrombocytopenia.pdf [10] Lecture slides: GC 088. Sudden Severe Chest Pain.pdf [11] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (SLE differential diagnosis section)
Diagnostic Criteria, Diagnostic Algorithm and Investigations for Ehlers-Danlos Syndrome
Unlike many conditions in medicine where a single blood test or imaging study confirms the diagnosis, EDS diagnosis relies on clinical criteria (for most subtypes) supplemented by genetic testing (for confirmable subtypes) and supported by targeted investigations to detect complications. There is no single "EDS blood test."
The diagnostic approach differs fundamentally by subtype:
- Hypermobile EDS (hEDS): Pure clinical diagnosis — no gene identified, no confirmatory lab test. Relies on the 2017 International Diagnostic Criteria
- Classical, Vascular, and other subtypes: Clinical suspicion → confirmed by molecular genetic testing (gene sequencing of the specific causative gene)
- Kyphoscoliotic EDS: Can also use a urinary biochemical assay (deoxypyridinoline/pyridinoline ratio) as an initial screen for lysyl hydroxylase deficiency, then confirmed genetically
The reason for this is simple: hEDS has no identified gene (likely polygenic), so you cannot do a genetic test. For the other subtypes, the gene is known, so sequencing provides definitive confirmation.
1. Diagnostic Criteria
A. Hypermobile EDS (hEDS) — 2017 International Diagnostic Criteria
This is the most commonly tested subtype in clinical practice and exams because it is the most common form and has the most detailed clinical criteria. The 2017 criteria (Malfait et al.) require ALL THREE of the following:
Criterion 1: Generalised Joint Hypermobility (GJH), assessed by the Beighton Score
Criterion 2: TWO or more of the following features (A, B, C):
- Feature A: Systemic manifestations of a generalised connective tissue disorder (≥ 5 must be present from a checklist)
- Feature B: Positive family history (first-degree relative independently meeting hEDS criteria)
- Feature C: Musculoskeletal complications (≥ 1 from a checklist: chronic pain, recurrent dislocations, atraumatic instability)
Criterion 3: All of the following prerequisites must be met:
- Absence of unusual skin fragility (which would suggest other EDS subtypes)
- Exclusion of other heritable and acquired connective tissue disorders (including other EDS subtypes, Marfan, Loeys-Dietz, OI)
- Exclusion of alternative diagnoses (autoimmune, inflammatory conditions)
| Manoeuvre | Points |
|---|---|
| Passive dorsiflexion of 5th MCP joint > 90° | 1 per hand (max 2) |
| Passive apposition of thumb to volar aspect of forearm | 1 per hand (max 2) |
| Hyperextension of elbow > 10° | 1 per arm (max 2) |
| Hyperextension of knee > 10° (genu recurvatum) | 1 per leg (max 2) |
| Forward flexion of trunk with knees extended, palms flat on floor | 1 |
| Total | /9 |
Age-adjusted cutoffs for GJH:
- Prepubertal children and adolescents: ≥ 6/9
- Pubertal men and women up to age 50: ≥ 5/9
- Adults > 50 years: ≥ 4/9
Why age-adjusted? Because joint laxity naturally decreases with age — collagen cross-linking increases over time, making joints stiffer. A score of 5 in a 60-year-old is therefore more significant than in a 15-year-old.
| System | Feature |
|---|---|
| Skin | Unusually soft or velvety skin |
| Skin | Mild skin hyperextensibility |
| Skin | Unexplained striae (distensae or rubrae) at back, groin, thighs, breasts, abdomen — without history of significant weight change, pregnancy, or glucocorticoid use |
| Skin | Bilateral piezogenic papules of the heel |
| Soft tissue | Recurrent or multiple abdominal herniae (inguinal, femoral, umbilical) |
| Soft tissue | Atrophic scarring at ≥ 2 sites (not papyraceous/haemosideric — those suggest classical EDS) |
| Musculoskeletal | Pelvic floor, rectal, or uterine prolapse in children, men, or nulliparous women |
| Musculoskeletal | Dental crowding AND high or narrow palate |
| Musculoskeletal | Arachnodactyly (positive on ≥ 1 of: wrist sign, thumb sign) |
| Musculoskeletal | Arm span-to-height ratio ≥ 1.05 |
| Cardiovascular | Mitral valve prolapse (mild or greater on echocardiography) |
| Cardiovascular | Aortic root dilatation with Z-score > +2 |
Important Distinction: hEDS vs Hypermobility Spectrum Disorder (HSD)
If a patient has generalised joint hypermobility with some musculoskeletal symptoms but does NOT meet all three criteria for hEDS, they are classified as having Hypermobility Spectrum Disorder (HSD). HSD is NOT a diagnosis of exclusion — it is a legitimate diagnosis, but it lacks the systemic connective tissue features required for hEDS. Think of it as: HSD = hypermobility + symptoms, but not enough features to call it EDS.
Clinical diagnosis (requires all three major criteria OR ≥ 1 major + ≥ 3 minor):
Major criteria:
- Skin hyperextensibility (standardised measurement: >1.5 cm dorsum of hand, >3 cm volar forearm/neck) + atrophic scarring
- Generalised joint hypermobility (Beighton ≥ 5 in adults)
Minor criteria:
- Easy bruising
- Soft, doughy skin
- Skin fragility (traumatic skin splitting)
- Molluscoid pseudotumours
- Subcutaneous spheroids
- Hernia (or history thereof)
- Epicanthal folds
- Complications of joint hypermobility (sprains, subluxations, dislocations, flat feet)
- Family history (1st degree relative meeting criteria)
Confirmatory: Molecular testing of COL5A1, COL5A2 (rarely COL1A1)
This is the most important subtype to diagnose early because of its life-threatening vascular complications.
Major criteria:
- Arterial rupture at a young age
- Spontaneous sigmoid colon perforation in the absence of known diverticular disease or other bowel pathology
- Uterine rupture during the third trimester in the absence of prior C-section or severe peripartum perineum tears
- Carotid-cavernous sinus fistula in the absence of trauma
Minor criteria:
- Bruising without identified trauma and/or in unusual sites (cheeks, back)
- Thin, translucent skin with visible venous pattern (especially chest, abdomen)
- Characteristic facial features (thin nose, thin lips, small chin, hollow cheeks, prominent eyes, lobeless ears)
- Spontaneous pneumothorax
- Acrogeria (aged appearance of the extremities, especially hands)
- Talipes equinovarus (clubfoot)
- Congenital hip dislocation
- Small joint hypermobility
- Tendon and muscle rupture
- Keratoconus
- Gingival recession and fragility
- Early-onset varicose veins (< 30 years, nulliparous if female)
Confirmatory: Molecular testing of COL3A1 (or rarely COL1A1 with specific arginine-to-cysteine substitutions). Genetic confirmation is essential for vEDS because the implications are so serious.
Critical Clinical Point
If you clinically suspect vEDS (e.g. young person with spontaneous arterial dissection + thin translucent skin + characteristic facies), you should avoid invasive diagnostic procedures (arteriography, surgical biopsies) whenever possible because of extreme tissue fragility → high risk of iatrogenic vascular injury. Use non-invasive imaging (CTA, MRA) and send blood for genetic testing instead.
Major criteria:
- Congenital muscle hypotonia
- Congenital or early-onset kyphoscoliosis (progressive)
- Generalised joint hypermobility with dislocations/subluxations (particularly shoulders, knees, hips)
Minor criteria:
- Skin hyperextensibility
- Easy bruisability
- Rupture/aneurysm of a medium-sized artery
- Marfanoid habitus
- Microcornea
- Radiographically considerable osteopenia
- Scleral fragility (risk of scleral/ocular globe rupture)
Confirmatory: Urinary deoxypyridinoline/pyridinoline ratio (elevated → indicates deficient lysyl hydroxylase activity). Molecular testing of PLOD1 or FKBP14.
This subtype has autosomal recessive inheritance [1]
The following algorithm represents the stepwise clinical approach when EDS is suspected:
Key Algorithmic Principle
The diagnostic algorithm is phenotype-driven: you look at the predominant clinical picture first, then apply the subtype-specific criteria, then confirm with genetic testing where available. You do NOT start with a genetic panel — you start with clinical assessment. Genetic testing is confirmatory, not screening.
3. Investigation Modalities
Investigations in EDS serve two purposes:
- Confirming the diagnosis (primarily genetic testing)
- Screening for and monitoring complications (the bulk of ongoing investigations)
| Test | Subtype | Details |
|---|---|---|
| Targeted gene sequencing | cEDS → COL5A1/A2; vEDS → COL3A1; kEDS → PLOD1; aEDS → COL1A1/A2 | First-line for specific clinical suspicion. Sanger sequencing or next-generation sequencing of the specific gene |
| Multi-gene panel ("Connective tissue disorders panel") | When subtype is unclear | Panels typically include COL3A1, COL5A1/A2, COL1A1/A2, FBN1, TGFBR1/2, SMAD3, PLOD1, TNXB, etc. Increasingly used as costs decrease |
| Whole exome/genome sequencing | Atypical presentations | When targeted panels are negative but clinical suspicion remains high |
| Skin biopsy for collagen biochemistry | vEDS (historical) | Cultured dermal fibroblasts analysed for Type III collagen production and structure by SDS-PAGE. Largely replaced by molecular testing but still used in some centres for vEDS when genetic results are ambiguous |
Interpretation considerations: A variant of uncertain significance (VUS) on genetic testing does not confirm or exclude EDS — it means the variant's pathogenicity is unclear. Clinical correlation is essential. A negative genetic test in the context of strong clinical features may indicate an uncharacterised subtype or a deep intronic/structural variant not detected by standard sequencing.
Genetic counselling with a 3-generation family tree and genetic screening should be offered [12], analogous to the approach for inherited cardiomyopathies.
These are important when a patient presents with easy bruising / bleeding tendency and EDS is in the differential:
| Investigation | Expected Finding in EDS | Rationale |
|---|---|---|
| CBC | Normal platelet count | The problem in EDS is the vessel wall, not the platelets |
| PT / INR | Normal | Extrinsic coagulation pathway is intact |
| aPTT | Normal | Intrinsic coagulation pathway is intact |
| Bleeding time / PFA-100 | May be prolonged | Platelet adhesion depends on subendothelial collagen (via vWF binding to GPIb and direct collagen-GPVI interaction). Defective collagen → impaired platelet adhesion → prolonged primary haemostasis. This is a vessel wall/collagen defect, not a platelet or coagulation defect |
| vWF antigen / activity | Normal | To exclude von Willebrand disease |
| Platelet aggregation studies | Usually normal (may show reduced collagen-induced aggregation) | The collagen agonist in the aggregation study uses exogenous collagen — this may still trigger aggregation normally. But in vivo, the endogenous subendothelial collagen is defective |
| Specific factor assays | Normal | To exclude haemophilia or specific factor deficiencies |
In the approach to bleeding disorders, physical examination for skin hyperelasticity indicates Ehlers-Danlos syndrome [3][8]
Interpretation Pearl
A patient with significant bruising history + completely normal CBC, PT, aPTT, and vWF assay should prompt examination of the skin and joints for EDS features. The normal coagulation workup is itself a diagnostic clue — it tells you the problem is not in the coagulation cascade or platelets, but in the vessel wall.
EDS is a connective tissue disease associated with inherited cardiac conditions. Cardiac manifestations include aortic root dilatation and mitral valve prolapse [1]
| Investigation | Purpose | Key Findings in EDS |
|---|---|---|
| Transthoracic Echocardiography (TTE) | Baseline and surveillance for aortic root dilatation, MVP, valvular regurgitation | Aortic root Z-score > +2 indicates dilatation (measure at the sinus of Valsalva level, similar to Marfan). MVP with or without mitral regurgitation. May see mild AR if root is dilated |
| CT Aortogram (CTA) with contrast | Gold standard for detecting aortic aneurysm, dissection, and peripheral arterial aneurysms | Preferred imaging modality for aortic dissection [2]. Intimal flap, true and false lumen, extent of dissection. Also identifies aneurysms in branch arteries (iliac, renal, splenic, mesenteric — particularly important in vEDS) |
| MR Angiography (MRA) | Alternative to CTA for vascular surveillance in vEDS (avoids radiation — important for young patients needing repeated imaging) | Arterial aneurysms, dissection, tortuosity. Takes longer (20–30 min), unsuitable for confused or claustrophobic patients, unsuitable for pacing wire and some life support equipment [2] |
| CXR | Screening for complications | Widening of the mediastinum (> 80% of aortic dissection cases) [2]. May also show pneumothorax (spontaneous, in some EDS subtypes) |
| ECG | Baseline | Usually normal. May show features of MVP (T wave inversions in inferior leads). If aortic dissection involves coronary arteries → ST changes mimicking ACS |
Surveillance protocol: In vEDS, current consensus recommends baseline vascular imaging (CTA or MRA from head to pelvis) at diagnosis, then periodic surveillance every 2–3 years or more frequently if abnormalities are detected. In hEDS and cEDS, baseline echocardiography is recommended, with follow-up interval determined by initial findings.
Aortic dissection in EDS: the underlying pathology is medial collagen and elastin degeneration [2][10]
| Investigation | Purpose | Key Findings |
|---|---|---|
| Plain radiographs (X-rays) | Assess for skeletal complications | Recurrent subluxations/dislocations (e.g., shoulder, patella). Premature osteoarthritis from joint instability. Kyphoscoliosis (in kEDS: measure Cobb angle on AP spine). Protrusio acetabuli (in overlap with Marfan-like features). Osteopenia (in kEDS, spEDS) |
| DEXA scan | Bone density assessment | Osteopenia/osteoporosis may be present in kEDS and spEDS (defective collagen cross-linking affects bone matrix). Also relevant in patients on long-term glucocorticoids for pain management |
| MRI spine | Assess for dural ectasia, cervical instability | Dural ectasia (widening of dural sac, usually lumbosacral) — shared feature with Marfan. Cervical instability in severe hypermobility → important before general anaesthesia |
| Investigation | Purpose | Key Findings |
|---|---|---|
| Skin biopsy with light microscopy | Generally non-specific for EDS | May show thin dermis (vEDS), fragmented collagen fibres |
| Skin biopsy with electron microscopy (EM) | Assess collagen fibril architecture | Classical EDS: "cauliflower" appearance of collagen fibrils (irregular diameter and cross-section due to defective Type V collagen regulation of fibrillogenesis). Dermatosparaxis EDS: hieroglyphic pattern of collagen fibrils. EM is NOT routinely needed for diagnosis but can support the diagnosis when genetic testing is inconclusive |
| Cultured fibroblast collagen analysis (SDS-PAGE) | Historically used for vEDS diagnosis | Abnormal Type III collagen production and/or migration pattern. Largely superseded by genetic testing |
| Investigation | Subtype | Details |
|---|---|---|
| Urinary deoxypyridinoline (DPD) / pyridinoline (PYD) ratio | Kyphoscoliotic EDS | Lysyl hydroxylase 1 (LH1) deficiency → reduced hydroxylysine in collagen → increased DPD/PYD ratio in urine. This is a screening test; a markedly elevated ratio is highly suggestive. Confirmed by PLOD1 genetic testing |
| Urinary total hydroxylysine | kEDS | Decreased in urine due to LH1 deficiency |
| Investigation | Indication | Key Findings |
|---|---|---|
| Colonoscopy (with caution in vEDS — risk of perforation) | GI symptoms, surveillance for bowel complications | Diverticulosis (may be absent in vEDS-related perforation — the perforation occurs through an apparently normal bowel wall). In vEDS, avoid routine colonoscopy unless absolutely necessary due to perforation risk |
| Ophthalmic examination (slit lamp) | All subtypes at baseline | To exclude ectopia lentis (which would point to Marfan instead). To assess for myopia, keratoconus (vEDS, BCS), scleral thinning (kEDS) |
| Autonomic function testing (tilt-table test) | hEDS with suspected POTS | Positive tilt-table test: sustained heart rate increase ≥ 30 bpm (or > 120 bpm) within 10 minutes of standing, without orthostatic hypotension. Confirms POTS as a comorbidity |
| PFT (Pulmonary Function Tests) | Restrictive lung disease from kyphoscoliosis | Restrictive pattern (reduced FVC and TLC) in kEDS with severe kyphoscoliosis |
| Investigation | hEDS | cEDS | vEDS | kEDS |
|---|---|---|---|---|
| Genetic testing | Not available (clinical diagnosis only) | COL5A1/A2 | COL3A1 | PLOD1/FKBP14 |
| Beighton Score | Essential (criterion 1) | Part of criteria | Limited value | Part of criteria |
| Echocardiography | Baseline recommended | Baseline recommended | Essential — monitor for aortic root dilatation, MVP [1] | Baseline recommended |
| CTA / MRA | Not routine | Not routine | Essential — baseline + surveillance every 2–3 years | If clinical concern |
| CBC, PT, aPTT | If bleeding tendency | If bleeding tendency | If bleeding tendency (usually normal) | If bleeding tendency |
| DEXA | If risk factors for osteoporosis | Not routine | Not routine | Recommended (osteopenia common) |
| Skin EM | Not indicated | Supportive if genetic testing inconclusive | Rarely needed | Not routine |
| Urine DPD/PYD ratio | Not applicable | Not applicable | Not applicable | Screening test |
| Ophthalmic exam | Baseline | Baseline | Baseline | Essential (ocular fragility) |
High Yield Summary — Diagnosis and Investigations of EDS
- hEDS is a clinical diagnosis only — 2017 criteria require: GJH (Beighton Score) + ≥ 2 of 3 feature categories + exclusion of other diagnoses. There is no genetic test.
- All other subtypes are confirmed by genetic testing of the specific causative gene.
- Beighton Score cutoffs: ≥ 6 (pre-pubertal), ≥ 5 (adult < 50), ≥ 4 (adult > 50).
- In bleeding workup: Normal CBC, PT, aPTT, vWF → think vessel wall defect → examine skin for hyperelasticity (EDS) [3].
- vEDS diagnosis: clinical suspicion → avoid invasive procedures → non-invasive imaging (CTA/MRA) + COL3A1 genetic testing.
- Echocardiography is essential — to assess for aortic root dilatation and MVP (shared with Marfan) [1].
- CTA is the preferred imaging for aortic dissection — nearly 100% sensitivity and specificity [2].
- Genetic counselling and family screening should be offered for all confirmed genetic subtypes [12].
- kEDS: urinary DPD/PYD ratio is a useful screening biochemical test before genetic confirmation.
- For suspected aortic dissection in EDS: CXR may show widened mediastinum (> 80% cases), CT aortogram with contrast is the definitive investigation [2].
Active Recall - Diagnosis and Investigations of EDS
References
[1] Lecture slides: GC 069. Inherited Cardiac conditions.pdf; Block A - Inherited Cardiac conditions.pdf [2] Senior notes: Block A - Sudden severe chest pain_ acute myocardial infarction; aortic dissection.pdf [3] Senior notes: Ryan Ho Haemtology.pdf (Section 4.1.2 - Approach to Bleeding Disorders) [4] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf [8] Senior notes: Adrian Lui Pediatrics Notes.pdf (Bleeding tendency physical examination) [10] Lecture slides: GC 088. Sudden Severe Chest Pain.pdf [12] Senior notes: Block A - Inherited Cardiac conditions.pdf (genetic counselling for inherited cardiac diseases)
Management of Ehlers-Danlos Syndrome
There is no cure for any subtype of EDS. The condition is caused by heritable mutations in structural proteins — you cannot replace defective collagen throughout the body. Therefore, management is:
- Preventive — minimise triggers for complications (e.g., avoid activities that stress fragile tissues)
- Supportive — treat symptoms (pain, instability, autonomic dysfunction)
- Surveillance — detect complications early (aortic dilatation, arterial aneurysm) before they become emergencies
- Emergency — manage acute life-threatening events (arterial rupture, bowel perforation, aortic dissection)
- Genetic counselling — inform patients and families about inheritance, reproductive risks, and family screening
The specific management strategy depends heavily on the EDS subtype, because the nature and severity of complications differ dramatically between, for example, hEDS (chronic pain and joint instability) and vEDS (arterial rupture and organ perforation).
1. Non-Pharmacological Management (All Subtypes)
This is the single most important intervention for hEDS — more important than any medication.
-
Targeted muscle strengthening: Strengthen muscles around hypermobile joints to provide dynamic stabilisation where ligaments fail
- Why does this work? Joints are stabilised by two systems: (1) passive restraints (ligaments, joint capsule — these are collagen-dependent and defective in EDS) and (2) active restraints (muscles and tendons providing dynamic stability). Since you cannot fix the ligaments, you strengthen the muscles to compensate
- Low-impact, progressive exercises: swimming, Pilates, clinical Pilates, hydrotherapy, cycling
- Avoid: high-impact activities, contact sports, heavy weightlifting, activities with sudden deceleration (e.g., sprinting, jumping)
-
Proprioceptive training: EDS patients have impaired proprioception (defective collagen in joint capsules → impaired mechanoreceptor signalling → poor joint position sense → increased injury risk)
- Balance boards, wobble cushions, closed-kinetic-chain exercises
-
Supportive footwear and orthotics [13] — for pes planus and ankle instability
-
Joint bracing / taping: Functional braces for unstable joints (particularly knee, ankle, wrist). Kinesiology taping can provide proprioceptive feedback
-
Occupational therapy: Adaptive strategies for daily activities, ergonomic modifications, assistive devices
Physiotherapy Prescription Principles in EDS
The key principle is "low load, high repetition" — you want to build endurance and neuromuscular control without overloading already-fragile tissues. High-intensity resistance training can worsen subluxations. A physiotherapist experienced in hypermobility is essential — generic physiotherapy advice (e.g., "just strengthen your quads") may be harmful if not tailored.
-
Wound closure: Use adhesive strips (Steri-Strips) or tissue adhesive instead of or in addition to sutures. If sutures are used:
- Leave sutures in for twice the normal duration (e.g., 14 days on limbs instead of 7)
- Use deep dermal sutures to take tension off the wound edges
- Apply tension-reducing wound closure strips after suture removal
- Why? Defective collagen → poor tensile strength during healing → wounds dehisce easily. Prolonged support reduces the risk of wound splitting and atrophic scar formation
-
Skin protection: Padding over bony prominences (shins, elbows, knees) to minimise minor trauma → reduce bruising and skin tears
-
Sun protection: To minimise UV damage to already-fragile skin
-
Avoid contact sports, isometric exercise (e.g., weight lifting, sit-ups, push-ups), and diving [6]
- Why contact sports? Risk of joint dislocation and tissue trauma
- Why isometric exercise? Increases systemic blood pressure acutely → in patients with aortic root dilatation or vascular fragility, this increases wall stress on the aorta → risk of dissection
- Why diving? Increases risk of pneumothorax (some EDS subtypes have pulmonary bullae)
-
Avoid excessive joint stretching ("party tricks" demonstrating hypermobility) — this worsens joint instability over time
-
MedicAlert identification: Especially for vEDS — emergency personnel need to know about tissue fragility, contraindication to certain procedures, and risk of spontaneous vascular events
- Chronic pain, disability, diagnostic delay, and the invisible nature of the condition (especially hEDS) contribute to significant psychological burden
- Cognitive behavioural therapy (CBT) — evidence-based for chronic pain management
- Pain psychology programmes — acceptance and commitment therapy (ACT)
- Peer support groups — EDS support organisations
2. Pharmacological Management
Pain is the predominant symptom in hEDS and is often the primary driver of disability. A stepwise approach:
| Step | Agent | Mechanism and Rationale | Cautions in EDS |
|---|---|---|---|
| 1. Simple analgesics | Paracetamol (acetaminophen) | Central COX inhibition → analgesic without anti-inflammatory effect. First-line for mild-moderate pain | Generally safe. Avoid hepatotoxic doses |
| 2. Topical agents | Topical NSAIDs (e.g., diclofenac gel), capsaicin cream, lidocaine patches | Local analgesic effect at painful joints without systemic side effects | Preferred over oral NSAIDs to avoid GI side effects (see below) |
| 3. Oral NSAIDs | Ibuprofen, naproxen | COX-1/2 inhibition → anti-inflammatory and analgesic | Use with caution in EDS — NSAIDs impair platelet function via COX-1 inhibition → exacerbate bleeding tendency in patients with already-fragile vessels. Also risk of GI bleeding (fragile GI mucosa). Use lowest effective dose for shortest duration |
| 4. Neuropathic pain agents | Amitriptyline, duloxetine, gabapentin, pregabalin | Central pain modulation — useful for the central sensitisation component of EDS pain (widespread pain, allodynia, hyperalgesia) | Amitriptyline: anticholinergic side effects, caution in POTS (worsens orthostatic intolerance). Duloxetine: preferred if concomitant depression/anxiety |
| 5. Referral to pain service | Multidisciplinary pain management programme | For refractory chronic pain. May include nerve blocks, TENS, acupuncture | Avoid opioids if possible (see below) |
Opioids in EDS
Avoid long-term opioids for chronic EDS pain. Opioids are ineffective for the central sensitisation component, cause tolerance and dependence, worsen GI dysmotility (already a problem in EDS), and cause constipation. Short-term use for acute events (e.g., joint dislocation, surgical recovery) is acceptable but should be time-limited.
B. Cardiovascular Pharmacotherapy
The principles are analogous to Marfan syndrome management:
-
Beta-blockers (e.g., atenolol, bisoprolol, or labetalol for acute situations)
- Why? Beta-blockers reduce heart rate and reduce dp/dt (the rate of rise of aortic pressure during systole). This decreases the haemodynamic stress on the aortic wall → slows the rate of aortic dilatation
- Beta-blockers and ACEIs/ARBs have been shown to reduce the rate of aortic dilatation in Marfan syndrome [6], and the same principle is applied to EDS with aortic involvement
-
ACEIs or ARBs (e.g., losartan, irbesartan)
- Why? ARBs (especially losartan) inhibit TGF-β signalling, which is implicated in aortic wall degeneration. The COMPARE trial showed losartan reduced the rate of aortic root dilatation in Marfan. The evidence in EDS is extrapolated from Marfan data
- ARBs are shown to reduce the rate of aortic dilatation [6]
- Celiprolol is a β1-blocker with β2-agonist properties (unique pharmacological profile)
- The landmark BBEST trial (2010, Ong et al.) demonstrated that celiprolol significantly reduced the incidence of arterial rupture and dissection in vEDS patients (number of arterial events reduced by approximately 5-fold)
- Why celiprolol specifically and not just any beta-blocker? The β2-agonist effect causes peripheral vasodilatation → reduces peripheral vascular resistance → reduces aortic wall stress. Simultaneously, the β1-blockade reduces heart rate and contractility. The combined effect provides optimal haemodynamic protection for fragile arteries. Standard beta-blockers (e.g., atenolol) lack this β2-agonist component
- Dose: 100 mg daily, titrated up to 200–400 mg daily
- Contraindications: Asthma (β-blocker class effect), severe bradycardia, decompensated heart failure
- Availability: Not universally available in all countries. In Hong Kong, celiprolol may need to be obtained through special access/named patient programmes. If unavailable, a standard beta-blocker (e.g., bisoprolol) is used as a substitute
High Yield: Celiprolol in Vascular EDS
Celiprolol is the only drug with randomised controlled trial evidence specifically in vascular EDS (the BBEST trial). It is considered first-line pharmacotherapy for vEDS. The name breaks down: "celi" → celective (selective), "pro" → propranolol-like, "lol" → beta-blocker suffix.
| Agent | Mechanism | Indication |
|---|---|---|
| Non-pharmacological first: Increased salt intake (2–3 g/day extra), increased fluid intake (2–3 L/day), compression stockings, graduated exercise | Expand intravascular volume and reduce venous pooling | First-line for all POTS patients |
| Fludrocortisone | Mineralocorticoid → promotes renal sodium and water retention → expands plasma volume | If non-pharmacological measures insufficient. Caution: hypokalaemia, supine hypertension |
| Midodrine | α1-agonist → vasoconstriction → increases venous return | For orthostatic hypotension/POTS. Avoid in supine hypertension |
| Ivabradine | Selective I(f) channel blocker → reduces heart rate without reducing blood pressure | For POTS with inappropriate sinus tachycardia. Does not lower BP (unlike beta-blockers, which may worsen orthostatic symptoms) |
| Low-dose propranolol | Non-selective beta-blocker → reduces heart rate | For POTS. Use cautiously — may worsen fatigue and orthostatic symptoms |
The management of aortic dissection in EDS follows the same principles as for any cause of dissection: [2]
-
Haemodynamic stabilisation — Medical treatment:
- Control BP → target SBP 100–120 mmHg
- IV labetalol first (combined α- and β-blocker → reduces heart rate, contractility, and BP simultaneously)
- Then IV nitroprusside if additional BP reduction needed
- Why labetalol BEFORE nitroprusside? If you give nitroprusside first (a pure vasodilator), it causes reflex tachycardia and increased contractility → increases aortic wall shear stress → worsens the dissection. You must lower contractility first with labetalol, then add vasodilator. [2]
-
Definitive treatment — Surgical:
- Type A dissection (ascending aorta involved) → Emergency surgical resection and graft [2]
- Type B dissection → Usually managed medically unless complicated (i.e., involvement of distal organs, rupture, retrograde dissection, or Marfan syndrome/EDS → in which case surgical/endovascular intervention) [2]
- In EDS/Marfan patients, Type B dissection has a lower threshold for surgical intervention because of the progressive nature of connective tissue weakness
Surgical Considerations in Vascular EDS
Surgical repair in vEDS is extremely technically challenging because of the friable tissue. Sutures tear through vessel walls easily. Surgeons must:
- Use pledgeted sutures (felt reinforcement at suture sites)
- Handle tissues with extreme gentleness
- Consider buttressing with Teflon felt strips
- Accept higher complication rates (re-bleeding, anastomotic leak)
Avoid unnecessary invasive procedures in vEDS patients whenever possible — this includes avoiding routine arteriography, colonoscopy, and elective surgeries unless the benefit clearly outweighs the risk.
| Agent | Indication | Details |
|---|---|---|
| Desmopressin (DDAVP) | Pre-procedural haemostatic prophylaxis | Releases vWF and Factor VIII from endothelial stores → augments primary haemostasis. May help reduce perioperative bleeding in EDS patients undergoing unavoidable surgery. Does NOT fix the underlying collagen defect but helps improve the haemostatic response |
| Tranexamic acid | Heavy menstrual bleeding, dental procedures, post-surgical bleeding | Antifibrinolytic → stabilises clot formation. Useful adjunct for mucosal bleeding |
| Ascorbic acid (Vitamin C) | Adjunctive in some subtypes (limited evidence) | Cofactor for prolyl and lysyl hydroxylases → optimises whatever collagen synthesis is possible. Evidence is anecdotal, not from RCTs. Will not correct a genetic defect but ensures the biosynthetic pathway is not additionally compromised by nutritional deficiency. Reasonable to supplement at physiological doses (500–1000 mg/day) |
| GI prokinetics (e.g., domperidone) | GI dysmotility in hEDS | For gastroparesis, chronic nausea, functional dyspepsia |
| PPIs (e.g., omeprazole) | GORD (common in hEDS due to oesophageal dysmotility and hiatal hernia) | Standard dosing |
3. Surgical Management
| Indication | Procedure | EDS-Specific Considerations |
|---|---|---|
| Recurrent joint dislocation not controlled by physiotherapy | Joint stabilisation surgery (e.g., capsulorrhaphy, ligament reconstruction, Laterjet procedure for shoulder) | High failure rate in EDS — defective collagen means reconstructed ligaments may stretch out again. Surgery should be a last resort after exhaustive conservative management. Post-operative rehabilitation must be prolonged |
| Severe kyphoscoliosis (kEDS) | Spinal fusion | Progressive scoliosis may cause cardiorespiratory compromise → spinal fusion indicated when Cobb angle is severe or rapidly progressive |
| Pelvic organ prolapse | Pelvic floor repair, sacrocolpopexy | Higher recurrence rate due to tissue fragility |
Indications for aortic surgery (analogous to Marfan): [6]
- Aortic root dilatation > 5 cm (lower threshold in vEDS — some centres intervene at 4.5 cm)
- Rapid enlargement > 1 cm/year
- Significant aortic regurgitation
- Family history of early dissection
| Procedure | Indication | Details |
|---|---|---|
| Aortic root replacement (Bentall procedure or valve-sparing root replacement) | Progressive aortic root dilatation meeting surgical threshold | Valve-sparing root replacement (David procedure) preferred if valve is structurally adequate — preserves native valve and avoids lifelong anticoagulation |
| Mitral valve repair / replacement | Severe mitral regurgitation from MVP with LV dysfunction or symptoms | Repair preferred over replacement where feasible |
| Emergency vascular repair | Arterial rupture, rapidly expanding aneurysm (vEDS) | Open surgical repair with pledgeted sutures. Endovascular repair (stent grafting) may be considered but carries risk of vessel injury at access site. Tissue fragility mandates extreme caution |
| Bowel surgery | Spontaneous bowel perforation (vEDS) | Emergency laparotomy with resection and primary anastomosis (or Hartmann's procedure for sigmoid perforation). Handle bowel with extreme care — serosa tears easily |
All surgeons and anaesthetists must be informed of the EDS diagnosis pre-operatively:
| Consideration | Rationale |
|---|---|
| Cervical spine instability | Hypermobile C-spine → risk of injury during intubation → consider fibreoptic intubation or careful direct laryngoscopy with manual in-line stabilisation |
| Difficult IV access | Fragile veins → easy haematoma. Use smallest gauge cannula possible. Ultrasound-guided access preferred |
| Positioning | Padded positioning to prevent skin tears and pressure injuries over bony prominences |
| Regional anaesthesia caution | Dural ectasia (lumbosacral) → unpredictable epidural/spinal spread. Higher risk of dural puncture headache. Bleeding into epidural space possible in vEDS |
| Wound closure | Extended suture time, tension-reducing techniques, adhesive strips |
| Avoid arterial lines in vEDS | Extreme arterial fragility → catastrophic bleeding from arterial line insertion |
| Blood products availability | Anticipate increased blood loss. Crossmatch blood pre-operatively |
| Subtype | Surveillance | Frequency |
|---|---|---|
| hEDS | Echocardiography (aortic root, MVP) | Baseline, then every 3–5 years if normal; annually if abnormal |
| cEDS | Echocardiography | Baseline, then as clinically indicated |
| vEDS | Echocardiography + CTA/MRA from head to pelvis (full arterial tree) | Baseline, then every 2–3 years; more frequently if abnormalities |
| kEDS | Echocardiography, spine radiographs, ophthalmology | Baseline, then annually |
| All subtypes | Ophthalmology review | Baseline (to exclude ectopia lentis → Marfan, and to assess for subtype-specific ocular findings) |
| All subtypes | DEXA if risk factors for osteoporosis | As clinically indicated |
-
Genetic counselling should be offered to all confirmed EDS patients [1][12]
- 3-generation pedigree construction
- Discussion of inheritance pattern (AD for most subtypes → 50% risk to offspring; AR for kEDS → 25% risk if both parents are carriers)
- Cascade screening of at-risk family members
-
Pre-conception counselling: Particularly critical for vEDS
- Maternal mortality in vEDS pregnancies is estimated at 5–12% — primarily from uterine rupture (third trimester) and arterial rupture (peripartum/postpartum)
- Patients must be fully informed of risks. Management should involve a multidisciplinary team (obstetrics, genetics, vascular surgery, anaesthesia)
- Delivery planning: early planned caesarean section (typically ~34–36 weeks) at a centre with vascular surgical backup
-
Prenatal/preimplantation genetic testing: Available for subtypes with known pathogenic variants
- Preimplantation genetic testing (PGT-M) with IVF → select embryos without the pathogenic variant
- Chorionic villus sampling (CVS) or amniocentesis → prenatal diagnosis (CVS at ~11 weeks, amniocentesis at ~16 weeks)
EDS management requires coordinated care across multiple specialties:
| Team Member | Role |
|---|---|
| Geneticist / Genetic counsellor | Diagnosis confirmation, family screening, reproductive counselling |
| Rheumatologist | Overall coordination, pain management, joint assessment |
| Cardiologist | Echocardiographic surveillance, aortic disease management, POTS |
| Vascular surgeon | Vascular surveillance and intervention (vEDS) |
| Physiotherapist (experienced in hypermobility) | Exercise prescription, joint stabilisation |
| Occupational therapist | Activity modification, assistive devices |
| Pain specialist | Chronic pain management |
| Dermatologist | Skin and wound care (cEDS, dEDS) |
| Gastroenterologist | GI dysmotility, GORD |
| Orthopaedic surgeon | Recurrent dislocations, scoliosis |
| Psychologist / Psychiatrist | CBT for chronic pain, anxiety, depression |
| Obstetrician (high-risk) | Pregnancy management (especially vEDS) |
| Management Domain | hEDS | cEDS | vEDS | kEDS |
|---|---|---|---|---|
| Physiotherapy | +++ (cornerstone) | ++ | + (gentle only) | ++ |
| Pain management | +++ | ++ | + | ++ |
| Skin/wound care | ± | +++ | ++ (thin skin) | ± |
| Beta-blocker | If aortic root dilated or POTS | If aortic root dilated | Celiprolol first-line | If aortic involvement |
| ACEI/ARB | If aortic root dilated | If aortic root dilated | Consider as adjunct | If aortic involvement |
| Vascular surveillance | Not routine | Not routine | Essential: CTA/MRA every 2–3 years | If clinical concern |
| Echocardiography | Baseline + periodic | Baseline + periodic | Essential + periodic | Baseline + periodic |
| Surgical intervention | Rarely needed | Rarely needed | Emergency vascular repair; elective aortic root replacement when threshold reached | Scoliosis surgery |
| Genetic counselling | Recommended | Essential | Essential [1] | Essential |
| Pregnancy counselling | Mild increased risk | Mild increased risk | Critical — 5–12% maternal mortality | Moderate risk |
| Activity restrictions | Avoid contact sports, isometric exercise [6] | Same | Strict — avoid all strenuous activity, contact, isometric | Gentle exercise only |
High Yield Summary — Management of EDS
- No cure exists — management is preventive, supportive, surveillance-based, and emergency-responsive
- Physiotherapy is the cornerstone for hEDS — low-load, high-repetition muscle strengthening to dynamically stabilise hypermobile joints
- Avoid contact sports, isometric exercise, and diving [6]
- Celiprolol is the only drug with RCT evidence in vEDS (BBEST trial) — β1-blocker with β2-agonist properties → reduces arterial events
- Beta-blockers and ACEIs/ARBs reduce the rate of aortic dilatation [6] — extrapolated from Marfan evidence
- Aortic surgery indications: root > 5 cm, rapid enlargement > 1 cm/year, significant AR, family history of early dissection [6]
- Acute aortic dissection management: IV labetalol first (reduce contractility), then nitroprusside (vasodilate). Give labetalol BEFORE nitroprusside to avoid reflex tachycardia worsening dissection [2]
- Type A dissection → emergency surgical resection and graft; Type B → medical unless complicated or connective tissue disease (lower threshold for surgery in EDS/Marfan) [2]
- vEDS pregnancy carries 5–12% maternal mortality — pre-conception counselling essential; planned early caesarean section
- Wound care in cEDS: prolonged suture retention, adhesive strips, tension-reducing closure, deep dermal sutures
- Avoid invasive procedures in vEDS whenever possible — tissue and vessel fragility cause iatrogenic harm
- Multidisciplinary team is essential: geneticist, rheumatologist, cardiologist, vascular surgeon, physiotherapist, pain specialist, psychologist
- Genetic counselling and family screening should be offered [1][12]
Active Recall - Management of EDS
References
[1] Lecture slides: GC 069. Inherited Cardiac conditions.pdf; Block A - Inherited Cardiac conditions.pdf [2] Senior notes: Block A - Sudden severe chest pain_ acute myocardial infarction; aortic dissection.pdf [6] Senior notes: Adrian Lui Pediatrics Notes.pdf (Marfan syndrome management — principles extrapolated to EDS) [12] Senior notes: Block A - Inherited Cardiac conditions.pdf (genetic counselling for inherited cardiac diseases) [13] Senior notes: Adrian Lui Pediatrics Notes.pdf (Hypermobility management — supportive footwear, orthotics)
Complications of Ehlers-Danlos Syndrome
The complications of EDS are direct consequences of defective collagen in specific tissues. To predict complications from first principles, ask: "Where is the affected collagen type predominantly expressed, and what happens when that tissue's structural integrity fails?"
- Collagen in ligaments/joint capsules → joint instability → dislocations, degenerative arthropathy
- Collagen in skin → poor wound healing, scarring, infection
- Collagen in blood vessel walls → aneurysm, dissection, rupture
- Collagen in hollow viscera → perforation
- Collagen in pelvic floor → prolapse
- Collagen in heart valves → MVP, aortic root dilatation, regurgitation
The severity and pattern of complications depend on the EDS subtype. Vascular EDS has the most lethal complication profile; hypermobile EDS has the most disabling (chronic pain, functional impairment) but least immediately life-threatening.
1. Cardiovascular Complications
- EDS is a connective tissue disease associated with inherited cardiac conditions [1]
- The cardiac manifestations include aortic root dilatation (which may lead to aortic regurgitation) and mitral valve prolapse — these are shared with Marfan syndrome [1]
- Pathophysiology: Defective collagen (especially Type III in vEDS, but also Type I and V in other subtypes) in the aortic wall → progressive weakening of the tunica media → dilatation of the aortic root (at the sinus of Valsalva) → loss of coaptation of aortic valve leaflets → aortic regurgitation (AR)
- Clinical significance: AR leads to LV volume overload → LV dilatation → eventual LV systolic dysfunction → heart failure if untreated
- Presentation: Early diastolic decrescendo murmur at the left sternal border, wide pulse pressure, bounding pulses (Corrigan's sign) in significant AR
Aortic dissection is a recognised complication in EDS. [2][5][10][14]
- Pathology: medial collagen and elastin degeneration → tear in the intima → blood enters the media → creates a false lumen → dissection extends proximally and/or distally [2]
- Causes of aortic dissection include: coexisting HT (80%), genetic diseases (Marfan syndrome, Familial aortic aneurysm/dissection, Ehlers-Danlos, Loeys-Dietz aneurysm syndrome), bicuspid aortic valve, and trauma [2][10]
- Stanford classification: [2]
- Type A: involves any part of the aorta proximal to the origin of the left subclavian artery (ascending aorta involved)
- Type B: all dissections not involving the ascending aorta (distal to left subclavian)
Complications of aortic dissection [5][14][15]:
Type A dissection complications:
- Aortic regurgitation — dissection extends into the aortic valvular annulus → early diastolic decrescendo murmur with wide pulse pressure [5]
- Cardiac tamponade — dissection ruptures into the pericardium → pericardial effusion → obstructive shock [5][14]
- Acute myocardial infarction — dissection extends into or compresses the coronary artery ostia (usually right coronary artery) → inferior STEMI pattern [5][14]
- This is critical because if you misdiagnose dissection as MI and give heparin and antiplatelet agents, the dissection will worsen — what stops the dissection is the thrombus within the aorta; without this thrombus, the dissection is free to keep extending [2]
- Focal neurological deficits — syncope, stroke (mostly Type A dissections) due to dissection propagating into carotid or brachiocephalic arteries [5]
- Paraplegia (spinal cord ischaemia)
- Altered level of consciousness (carotid artery involvement)
- Horner syndrome (superior cervical ganglion compression)
- Hoarseness (left recurrent laryngeal nerve compression) [5]
Type B dissection complications:
- Dissection into abdominal aortic branches → coeliac / renal / lower limb ischaemia [14]
- Focal neurological deficits related to spinal ischaemia [14]
- Haemothorax (rupture into left pleural space)
Prognosis of dissection without treatment: [2]
- Very poor — approximately 1% mortality per hour within the first 48 hours → ~50% dead in 2 days
- Survival exceeds 90% with prompt diagnosis and management
- Death results from progression of dissection → vascular compromise or rupture
- This is the leading cause of death in vascular EDS
- Unlike Marfan (where the aortic root is the primary site), vEDS characteristically affects medium-sized arteries: iliac, renal, splenic, mesenteric, hepatic, and coronary arteries
- Pathophysiology: Defective Type III collagen → weakened arterial wall → progressive aneurysmal dilatation → spontaneous rupture → massive internal haemorrhage → haemorrhagic shock and death
- Presentation: Sudden severe abdominal, flank, or chest pain → haemodynamic collapse → shock. May present without warning in a previously asymptomatic young person
- Median age of first major vascular event in vEDS: ~20–30 years
- Median survival in untreated vEDS: ~50 years (death usually from arterial rupture)
- MVP is a complication/association of EDS and Marfan syndrome [1][16]
- Pathophysiology: Myxomatous degeneration of mitral valve leaflets — collagen is a key structural component of valve leaflets. Defective collagen → redundant, floppy leaflets that prolapse into the left atrium during systole
- Auscultation: Mid-systolic click ± late systolic murmur, best heard at the apex [16]
- Complications of MVP: [16]
- Progressive severe mitral regurgitation → may require mitral valve repair/replacement
- Emboli (embolic stroke)
- Atrial fibrillation
- Infective endocarditis (rare, but MVP is a predisposing factor for valvular vegetation)
MVP causes include: isolated/primary (common in females) and secondary to connective tissue diseases (Marfan, EDS, OI), SLE, and PCKD [15]
2. Gastrointestinal Complications
- The most characteristic GI complication of vEDS — occurs in approximately 15–25% of vEDS patients during their lifetime
- Pathophysiology: Type III collagen is a major structural component of the bowel wall (serosa, muscularis). Defective Type III collagen → weakened bowel wall → spontaneous perforation without precipitating factors (no diverticular disease, no trauma)
- Most common site: Sigmoid colon (analogous to where diverticular perforation occurs in the general population — the sigmoid has the highest intraluminal pressures due to Laplace's law, and a relatively thinner wall)
- Presentation: Acute abdomen — sudden severe abdominal pain, guarding, rigidity, rebound tenderness → peritonitis → septic shock if not treated urgently
- Recurrence: High recurrence rate — patients who survive one perforation are at risk for subsequent perforations
- Important: Avoid routine colonoscopy in vEDS unless absolutely clinically necessary — the procedure itself risks perforation in the fragile bowel wall
- Chronic constipation, gastroparesis, functional dyspepsia, IBS-like symptoms
- Pathophysiology: Connective tissue laxity in the bowel wall → impaired peristalsis → dysmotility. Also possible autonomic dysfunction (associated POTS → impaired enteric nervous system regulation)
- Not life-threatening but significantly impairs quality of life
- Common in hEDS — hiatal hernia from connective tissue laxity → reflux
- May present with chest pain, dysphagia, odynophagia
3. Musculoskeletal Complications
- The hallmark musculoskeletal complication, particularly in hEDS and cEDS
- Most commonly affected: shoulder (glenohumeral), patella, TMJ, fingers (MCP, PIP), ankle, hip
- Pathophysiology: Defective collagen in ligaments and joint capsules → loss of passive joint restraint → joints exceed normal range of motion under physiological loads → subluxation (partial displacement) or frank dislocation
- With each dislocation episode, further damage occurs to the already-deficient capsulolabral structures → progressive instability (a vicious cycle)
- In arthrochalasia EDS: congenital bilateral hip dislocation is pathognomonic
- The most disabling complication of hEDS — often exceeds the impact of the hypermobility itself
- Pathophysiology (multifactorial):
- Peripheral nociceptive pain: Repetitive microtrauma from joint instability → local inflammation → nociceptor activation
- Neuropathic pain: Nerve entrapment from joint instability (e.g., carpal tunnel from wrist hypermobility)
- Central sensitisation: Chronic peripheral nociceptive input → spinal cord dorsal horn upregulation → hyperalgesia and allodynia → pain becomes self-perpetuating even without ongoing tissue damage
- Psychological amplification: Chronic pain → anxiety, depression, catastrophising → amplification of pain perception
- Chronic pain in hEDS is notoriously difficult to treat and is the primary reason for disability claims
- Pathophysiology: Joint instability → abnormal biomechanical loading → accelerated cartilage wear → early-onset degenerative osteoarthritis
- Patients may develop radiographic OA in their 30s–40s, decades earlier than expected
- Commonly affects weight-bearing joints (knees, hips) and frequently-subluxating joints (shoulders)
- Particularly in kEDS and spEDS
- Pathophysiology: Collagen is the organic scaffold of bone (Type I collagen constitutes ~90% of bone organic matrix). Defective collagen or defective collagen cross-linking (kEDS — lysyl hydroxylase deficiency) → reduced bone matrix integrity → osteoporosis
- In other subtypes, reduced physical activity due to pain/disability may contribute to disuse osteopenia
- Chronic TMJ subluxation, clicking, locking, pain
- May cause difficulty eating, speaking
4. Dermatological Complications
- Pathophysiology: Defective collagen deposition during the proliferative phase of wound healing → reduced tensile strength of scar tissue → wounds that were closed may dehisce; healed wounds form widened, atrophic, papyraceous ("cigarette-paper") scars
- Most prominent in classical EDS — scars over bony prominences (shins, knees, elbows, forehead) are characteristic
- Surgical implication: Post-operative wound dehiscence is a significant risk. Sutures must remain longer and wounds require reinforcement
- Pathophysiology: Fragile dermal and subcutaneous blood vessels (collagen-deficient vessel walls) → minor trauma causes capillary rupture → extravasation → bruising
- In vEDS, bruising can be extensive and spontaneous, mimicking coagulopathy or non-accidental injury
- Molluscoid pseudotumours: Fleshy, raised scar-associated lesions over pressure points — represent fat herniation through weakened dermal collagen at sites of prior scarring
- Subcutaneous spheroids: Small, hard, mobile calcified nodules palpable beneath the skin (forearms, shins) — represent calcified subcutaneous fat lobules from prior subcutaneous haemorrhage
5. Respiratory Complications
- Pathophysiology: Defective collagen in pleural tissue and lung parenchyma → development of subpleural bullae/blebs (especially upper lobes) → spontaneous rupture → pneumothorax
- More common in vEDS and Marfan (shared complication)
- This is why diving is contraindicated in EDS [6] — increased intrathoracic pressure + Boyle's law (gas expansion on ascent) → increased risk of bullae rupture → pneumothorax at depth → potentially fatal tension pneumothorax
- Severe progressive kyphoscoliosis → reduced thoracic cage compliance → restrictive ventilatory defect → may eventually cause respiratory failure/cor pulmonale if untreated
6. Obstetric and Gynaecological Complications
- The most feared obstetric complication — Type III collagen is a structural component of the uterine wall (especially myometrium)
- Defective Type III collagen → weakened uterus → spontaneous rupture during the third trimester or during labour
- Maternal mortality: Estimated 5–12% per pregnancy in vEDS
- Management: Pre-conception counselling, planned early caesarean section (~34–36 weeks), delivery at a centre with vascular surgical backup
- Defective collagen in the amniotic membranes → membranes rupture prematurely → PPROM → preterm delivery
- Relevant across multiple EDS subtypes, not just vEDS
- Pathophysiology: Defective collagen in pelvic floor support structures (uterosacral ligaments, cardinal ligaments, endopelvic fascia) → uterine prolapse, cystocele, rectocele
- Can occur in young nulliparous women or even children (a diagnostic clue to underlying EDS)
- Pathophysiology: Two mechanisms:
- Defective endometrial vessel collagen → impaired vasoconstriction after menstrual shedding → prolonged bleeding
- Impaired platelet-collagen interaction (subendothelial collagen is the primary trigger for platelet adhesion via GPIb-vWF) → impaired primary haemostasis
7. Neurological Complications
- Hypermobility of the cervical spine (especially atlanto-axial and atlanto-occipital joints) → instability → risk of spinal cord compression → myelopathy
- Symptoms: neck pain, headaches, upper limb paraesthesiae, gait disturbance, long tract signs (hyperreflexia, Babinski positive)
- Important for anaesthesia: Cervical instability must be assessed pre-operatively; intubation requires careful technique
- Increasingly reported association between hEDS and Chiari I malformation (cerebellar tonsillar descent > 5 mm below the foramen magnum)
- Pathophysiology: Speculation that connective tissue laxity at the craniocervical junction allows downward herniation of the cerebellar tonsils
- Symptoms: occipital headaches worse with Valsalva, cervicogenic headache, syringomyelia
- Widening of the dural sac (lumbosacral spine) — shared with Marfan
- Pathophysiology: Defective collagen in dura → progressive expansion under CSF pressure → erosion of vertebral bone
- Usually asymptomatic but can cause low back pain, radicular symptoms, headache
- Anaesthetic implication: Dural ectasia may cause unpredictable distribution of epidural/spinal anaesthetic drugs and increases the risk of dural puncture
| Complication | Subtype | Pathophysiology |
|---|---|---|
| Keratoconus | vEDS | Defective corneal collagen → progressive corneal thinning and conical protrusion → irregular astigmatism, visual distortion |
| Scleral fragility / globe rupture | kEDS, BCS | Defective scleral collagen → extremely thin sclera → risk of rupture from minor blunt trauma |
| Myopia | Multiple subtypes | Increased axial globe length due to scleral laxity |
| Retinal detachment | kEDS | Vitreoretinal collagen abnormalities → increased risk |
| Blue sclerae | BCS, some kEDS | Thinned scleral collagen allows underlying uveal pigment to show through |
9. Autonomic Dysfunction (Especially hEDS)
- Present in an estimated 30–80% of hEDS patients
- Pathophysiology: Connective tissue laxity in venous walls → excessive venous compliance → peripheral venous pooling on standing → reduced venous return → reduced cardiac output → baroreceptor-mediated reflex tachycardia (heart rate ≥ 30 bpm increase or > 120 bpm within 10 min of standing, without significant drop in BP)
- Symptoms: lightheadedness, presyncope, palpitations, exercise intolerance, brain fog, fatigue
- Gastrointestinal dysmotility (gastroparesis, constipation)
- Temperature dysregulation
- Abnormal sweating patterns
- Bladder dysfunction
- Chronic pain → depression, anxiety, catastrophising (very common in hEDS)
- Diagnostic delay (average > 10 years for hEDS) → frustration, medical mistrust, healthcare avoidance
- Functional disability: inability to work, reduced physical activity, social isolation
- Sleep disturbance: pain-mediated, positional discomfort, associated sleep apnoea (pharyngeal laxity in some cases)
These are complications caused by medical/surgical interventions in patients with EDS — particularly important in vEDS:
| Complication | Context | Pathophysiology |
|---|---|---|
| Vascular injury from arterial access | Arteriography, arterial line insertion in vEDS | Fragile arterial walls → iatrogenic dissection, pseudoaneurysm, uncontrollable bleeding |
| Wound dehiscence | Post-surgical in cEDS, vEDS | Defective collagen in wound → failed healing → suture pull-through |
| Bowel perforation during colonoscopy | vEDS | Fragile bowel wall → instrumental perforation |
| Haemorrhage from biopsy sites | Skin biopsy, organ biopsy in vEDS | Vessel fragility → excessive bleeding from even minor procedures |
| Post-dural puncture headache | Epidural/spinal anaesthesia | Dural ectasia → increased risk of inadvertent dural puncture; thin dura may not seal well |
Clinical Pearl: Iatrogenic Harm
In vEDS, the biggest risk to the patient is often the medical system itself. Well-meaning but uninformed clinicians may order invasive investigations (angiography, colonoscopy, biopsies) that carry catastrophic risk in vEDS. Always ensure the EDS diagnosis (especially vEDS) is prominently documented, and consider wearing a MedicAlert bracelet stating "Vascular Ehlers-Danlos — avoid invasive procedures."
| System | Complication | hEDS | cEDS | vEDS | kEDS |
|---|---|---|---|---|---|
| Cardiovascular | Aortic root dilatation / AR | ± | ± | ++ | ± |
| Aortic dissection | Rare | Rare | +++ | Rare | |
| Medium artery rupture | − | − | +++ | ± | |
| MVP | ++ | + | ± | ± | |
| GI | Bowel perforation | − | − | +++ | − |
| Dysmotility / GORD | ++ | ± | ± | ± | |
| MSK | Recurrent dislocations | +++ | ++ | ± | ++ |
| Chronic pain | +++ | ++ | + | ++ | |
| Premature OA | ++ | + | − | + | |
| Dermatological | Atrophic scarring | ± | +++ | ± | ± |
| Easy bruising | + | ++ | +++ | + | |
| Respiratory | Pneumothorax | ± | − | ++ | ± |
| Restrictive lung disease | − | − | − | ++ | |
| Obstetric | Uterine rupture | − | − | +++ | − |
| PPROM | + | + | ++ | + | |
| Pelvic organ prolapse | ++ | + | ± | + | |
| Neurological | Cervical instability | + | ± | − | ± |
| Dural ectasia | + | ± | − | ± | |
| Ocular | Globe rupture | − | − | − | ++ |
| Keratoconus | − | − | + | − | |
| Autonomic | POTS | +++ | ± | − | − |
| Psychological | Depression, anxiety | +++ | + | ++ | + |
High Yield Summary — Complications of EDS
- EDS is a connective tissue disease associated with inherited cardiac conditions — cardiac manifestations include aortic root dilatation, aortic regurgitation, and mitral valve prolapse [1]
- Aortic dissection in EDS results from medial collagen and elastin degeneration. Causes include EDS, Marfan, Loeys-Dietz, FTAAD, bicuspid aortic valve, and hypertension (80%) [2][10]
- Complications of Type A dissection: AR, cardiac tamponade, AMI, stroke, paraplegia, Horner syndrome, hoarseness [5]
- Complications of Type B dissection: coeliac/renal/lower limb ischaemia, spinal ischaemia [14]
- Untreated aortic dissection: ~1% mortality per hour in first 48 hours; > 90% survival with prompt treatment [2]
- vEDS: Leading cause of death is arterial rupture (medium-sized arteries); also spontaneous bowel perforation and uterine rupture
- hEDS: Leading cause of disability is chronic pain syndrome (peripheral + central sensitisation)
- MVP complications: progressive MR requiring valve surgery, embolic stroke, atrial fibrillation [16]
- Iatrogenic complications are a major risk in vEDS — avoid invasive procedures when possible
- Pneumothorax risk is why diving is contraindicated [6]
- POTS occurs in 30–80% of hEDS patients due to venous laxity → excessive pooling → reflex tachycardia
- Obstetric: vEDS pregnancy carries 5–12% maternal mortality from uterine/arterial rupture
Active Recall - Complications of EDS
References
[1] Lecture slides: GC 069. Inherited Cardiac conditions.pdf; Block A - Inherited Cardiac conditions.pdf [2] Senior notes: Block A - Sudden severe chest pain_ acute myocardial infarction; aortic dissection.pdf [4] Lecture slides: GC 199. Pulsating abdominal mass aortic aneurysm.pdf [5] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf; MBBS Final MB (Surgery) (Felix PY Lai).pdf [6] Senior notes: Adrian Lui Pediatrics Notes.pdf (Marfan syndrome management section) [10] Lecture slides: GC 088. Sudden Severe Chest Pain.pdf [14] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Complications of aortic dissection, p. 909) [15] Senior notes: Maksim Medicine Notes.pdf (Valvular heart disease — MVP causes and complications) [16] Senior notes: Block A - Fever and a murmur_ Valvular heart diseases; Infective endocarditis.pdf (MVP complications)
High Yield Summary
Ehlers-Danlos Syndrome — Key Points for HKUMed Summative Exams:
- Definition: Group of heritable connective tissue disorders due to defective collagen (various types)
- Most common subtype: Hypermobile EDS (hEDS) — no identified gene, clinical diagnosis
- Most dangerous subtype: Vascular EDS (vEDS) — COL3A1 → Type III collagen deficiency → arterial rupture, bowel perforation, uterine rupture
- Classical EDS: COL5A1/COL5A2 → atrophic scarring, skin hyperextensibility, joint hypermobility
- Inheritance: Mostly AD (hEDS, cEDS, vEDS); some subtypes AR (kEDS, dEDS)
- Clinical triad: Joint hypermobility + Skin hyperextensibility + Tissue fragility
- Beighton Score: Used to assess generalised joint hypermobility (0–9)
- Cardiac manifestations: MVP, aortic root dilatation (shared with Marfan), arterial aneurysm/dissection (especially vEDS)
- Bleeding tendency: Normal PT/aPTT, defective collagen → impaired vessel wall integrity and platelet adhesion → easy bruising
- EDS is listed as a connective tissue disease associated with inherited cardiac conditions (along with Marfan, Loeys-Dietz, familial thoracic aortic aneurysm/dissection, and bicuspid aortic valvulopathy) [1]
- EDS type IV (vascular) is a genetic cause of AAA alongside Marfan syndrome [4]
- EDS is a cause of aortic dissection alongside hypertension, Marfan syndrome, and Loeys-Dietz syndrome [2][5]
High Yield Summary — Differential Diagnosis of EDS
- Joint hypermobility DDx: Benign hypermobility spectrum disorder (milder), Marfan (tall + lens subluxation), Loeys-Dietz (bifid uvula + arterial tortuosity), Osteogenesis Imperfecta (fractures + blue sclerae), Stickler (vitreoretinal + hearing loss)
- Skin DDx: Cutis laxa (skin does NOT recoil), PXE (yellowish papules + angioid streaks)
- Bleeding DDx: vWD (abnormal vWF assay), platelet disorders (abnormal aggregation), HHT (telangiectasiae), scurvy (perifollicular haemorrhage), child abuse (inconsistent history)
- Aortic/Vascular DDx: Marfan, Loeys-Dietz, FTAAD, Bicuspid aortic valvulopathy [1] — the inherited aortopathy family
- Physical examination clue: skin hyperelasticity → think EDS; telangiectasiae on lips/fingertips → think HHT [3]
- EDS and Marfan are both connective tissue diseases associated with inherited cardiac conditions [1]
- EDS is a recognised genetic cause of aortic dissection alongside Marfan, Loeys-Dietz, and FTAAD [2][5][10]
High Yield Summary — Diagnosis and Investigations of EDS
- hEDS is a clinical diagnosis only — 2017 criteria require: GJH (Beighton Score) + ≥ 2 of 3 feature categories + exclusion of other diagnoses. There is no genetic test.
- All other subtypes are confirmed by genetic testing of the specific causative gene.
- Beighton Score cutoffs: ≥ 6 (pre-pubertal), ≥ 5 (adult < 50), ≥ 4 (adult > 50).
- In bleeding workup: Normal CBC, PT, aPTT, vWF → think vessel wall defect → examine skin for hyperelasticity (EDS) [3].
- vEDS diagnosis: clinical suspicion → avoid invasive procedures → non-invasive imaging (CTA/MRA) + COL3A1 genetic testing.
- Echocardiography is essential — to assess for aortic root dilatation and MVP (shared with Marfan) [1].
- CTA is the preferred imaging for aortic dissection — nearly 100% sensitivity and specificity [2].
- Genetic counselling and family screening should be offered for all confirmed genetic subtypes [12].
- kEDS: urinary DPD/PYD ratio is a useful screening biochemical test before genetic confirmation.
- For suspected aortic dissection in EDS: CXR may show widened mediastinum (> 80% cases), CT aortogram with contrast is the definitive investigation [2].
High Yield Summary — Management of EDS
- No cure exists — management is preventive, supportive, surveillance-based, and emergency-responsive
- Physiotherapy is the cornerstone for hEDS — low-load, high-repetition muscle strengthening to dynamically stabilise hypermobile joints
- Avoid contact sports, isometric exercise, and diving [6]
- Celiprolol is the only drug with RCT evidence in vEDS (BBEST trial) — β1-blocker with β2-agonist properties → reduces arterial events
- Beta-blockers and ACEIs/ARBs reduce the rate of aortic dilatation [6] — extrapolated from Marfan evidence
- Aortic surgery indications: root > 5 cm, rapid enlargement > 1 cm/year, significant AR, family history of early dissection [6]
- Acute aortic dissection management: IV labetalol first (reduce contractility), then nitroprusside (vasodilate). Give labetalol BEFORE nitroprusside to avoid reflex tachycardia worsening dissection [2]
- Type A dissection → emergency surgical resection and graft; Type B → medical unless complicated or connective tissue disease (lower threshold for surgery in EDS/Marfan) [2]
- vEDS pregnancy carries 5–12% maternal mortality — pre-conception counselling essential; planned early caesarean section
- Wound care in cEDS: prolonged suture retention, adhesive strips, tension-reducing closure, deep dermal sutures
- Avoid invasive procedures in vEDS whenever possible — tissue and vessel fragility cause iatrogenic harm
- Multidisciplinary team is essential: geneticist, rheumatologist, cardiologist, vascular surgeon, physiotherapist, pain specialist, psychologist
- Genetic counselling and family screening should be offered [1][12]
High Yield Summary — Complications of EDS
- EDS is a connective tissue disease associated with inherited cardiac conditions — cardiac manifestations include aortic root dilatation, aortic regurgitation, and mitral valve prolapse [1]
- Aortic dissection in EDS results from medial collagen and elastin degeneration. Causes include EDS, Marfan, Loeys-Dietz, FTAAD, bicuspid aortic valve, and hypertension (80%) [2][10]
- Complications of Type A dissection: AR, cardiac tamponade, AMI, stroke, paraplegia, Horner syndrome, hoarseness [5]
- Complications of Type B dissection: coeliac/renal/lower limb ischaemia, spinal ischaemia [14]
- Untreated aortic dissection: ~1% mortality per hour in first 48 hours; > 90% survival with prompt treatment [2]
- vEDS: Leading cause of death is arterial rupture (medium-sized arteries); also spontaneous bowel perforation and uterine rupture
- hEDS: Leading cause of disability is chronic pain syndrome (peripheral + central sensitisation)
- MVP complications: progressive MR requiring valve surgery, embolic stroke, atrial fibrillation [16]
- Iatrogenic complications are a major risk in vEDS — avoid invasive procedures when possible
- Pneumothorax risk is why diving is contraindicated [6]
- POTS occurs in 30–80% of hEDS patients due to venous laxity → excessive pooling → reflex tachycardia
- Obstetric: vEDS pregnancy carries 5–12% maternal mortality from uterine/arterial rupture
Factor V Leiden
Factor V Leiden is a genetic mutation (Arg506Gln) in coagulation factor V that renders it resistant to inactivation by activated protein C, resulting in a hereditary hypercoagulable state with increased risk of venous thromboembolism.
Prothrombin G20210A Mutation
Prothrombin G20210A mutation is a hereditary point mutation in the 3' untranslated region of the prothrombin gene that leads to elevated plasma prothrombin levels and an increased risk of venous thromboembolism.